Loading content
Professor Clive Ballard

Professor Clive Ballard

Pro-Vice Chancellor and Executive Dean

 2911

 722911

 Medical School Building F.04

 

Medical School Building, St Luke's Campus, Magdalen Road, Exeter, EX1 2LU, UK

Clive Ballard had the unfair advantage of being born Welsh and brought up as a Swansea city fan, before studying Medicine in Leicester. Clive then studied psychiatry in Coventry and Birmingham before specialising in the psychiatry of older adults. He moved to Newcastle as an MRC Clinical Fellow and Senior Lecturer in 1995 to join the world leading dementia with the Lewy Body Dementia research group. Clive then moved to the Institute of Psychiatry at King’s College London in 2003 as Professor of Age-Related Diseases, where he directed the NIHR Biomedical Research Unit for Dementia and codirected the Wolfson Centre for Age-Related Disease. From 2003 to 2013 Clive was also Director of Research for the Alzheimer’s Society and played a key role in the successful campaign to overturn a NICE decision and make anti-dementia drugs available for people with dementia. Over this period Clive published more than 200 research papers including key clinical trials focussing on the treatment of dementia with Lewy bodies, dementia in people with Down’s syndrome, vascular dementia and neuropsychiatric symptoms in dementia.

Clive was delighted to join the University of Exeter as Pro-Vice Chancellor and Executive Dean of the Medical School in November 2016 and looks forward to working with the tremendous team of researchers and educators, and further building the excellence of the Medical School.

Qualifications

Education and awards

1987 - Leicester University, MB ChB (Medicine)
1991 - University of Birmingham, MMedSci
1992 - University of Birmingham, M.R.C.Psych.
1995 - Leicester University, MD
2015 - Fellow Academy Medical Sciences

Career

Current and previous posts

1992–1995: Lecturer in Psychiatry, University of Birmingham
1995–2000: MRC clinical Fellow/Senior Lecturer Old Age Psychiatry, University of Newcastle
2000–2002: Reader in Old Age Psychiatry, University of Newcastle, UK
2002–2003: Professor of Old Age Psychiatry, University of Newcastle, UK
2003–2013: Director of Research, Alzheimer’s Society
2003–2016: Professor of Age Related Diseases, King’s College London
2016–present: Executive Dean of Medicine, University of Exeter

 

Research

Research interests

Clive’s work has highlighted the harms of antipsychotic medications in people with dementia, and made a massive contribution to the 50% reduction in the use of these agents nationally and internationally. Further work has demonstrated the benefits of non-pharmacological treatments for the management of agitation in people with dementia. Clive has led studies which highlighted the substantial benefits in neuropsychiatric symptoms from more effective treatment of pain and he has led a pivotal study with the novel and safer antipsychotic pimavanserin for the treatment of psychosis in people with Parkinson’s disease psychosis. Ongoing clinical trials include a randomised control trial of pimavanserin for the treatment of psychosis and a trial of mirtazapine for the treatment of agitation in people with Alzheimer’s disease. Other current work includes the SMART-AD drug discovery programme funded by the Wellcome Trust, the IDEA European Union programme focussing on stem cells as a potential treatment for neurodegenerative disorders and the MRC Deep and Frequent Phenotyping cohort study.

An additional strand of work in Clive’s portfolio has focussed on the maintenance of cognitive health and the prevention of cognitive decline. Key clinical trials have demonstrated the potential utility of online brain training trials for maintaining cognitive health and function in later life. Building on this, the ongoing PROTECT programme is an online cohort study supported by more than 20,000 participants over the age of 50, with nested intervention studies including further studies of brain training. This will shortly include new studies of physical exercise and natural products to maintain cognitive health.

Selected Current Grants

Duration: 2017-2022
Funding Agency: NIHR
Name: BRC for Mental Health 
Costs: £63m
Applicants: Lead applicant Hoptof (Ballard lead applicant for dementia theme)

Duration: 2016-2019
Funding Agency: MRC
Name: Deep and Frequent Phenotyping 
Costs: £6m
Applicants: Lead applicant Lovestone

Duration: 2013-2017
Funding Agency: ACADIA pharmaceutical Company
Name: An RCT of pimavanserin for Alzheimer’s psychosis 
Costs: £10m
Applicants: Lead applicant Ballard

Duration: 2014-2019
Funding Agency: Wellcome Trust
Name: Alzheimer’s Disease drug discovery (SMART-AD)
Costs: £1.8m
Applicants: Lead applicant Ballard

Duration: 2010-2016
Funding Agency: NIHR
Name: An optimized intervention to reduce and treat behavioural symptoms in people with dementia living in care homes 
Costs: £2m
Applicants: Lead applicant Ballard

Duration: 2013-2018
Funding Agency: MRC
Name: An RCT of minocycline for the treatment of Alzheimer’s disease
Costs: £2.6m
Applicants: Lead applicant Howard (Ballard co-PI)

Duration: 2012-2017
Funding Agency: NIHR
Name: Maudsley Biomedical Research Unit for Dementia
Costs: £4.5m
Applicants: Director Clive Ballard

Duration: 2013-2017
Funding Agency: Nova Nordisk /Alzheimer’s Society /Alzheimer’s Drug Discovery Foundation 
Name: Evaluating the effects of the novel GLP-1 analogue, Liraglutide in patients with Alzheimer’s disease.
Costs: £1.7m
Applicants: Lead applicant Edison (Ballard co-PI)

Duration: 2011-2017
Funding Agency: European Union
Name: Therapeutic Opportunities of Stem Cell Therapies
Costs: £5m
Applicants: Lead applicant Pison (Ballard co-PI, UK lead)

Funding Agency: ARUK
Name: Alzheimer’s Research UK Oxford Drug Discovery Institute
Costs: £10m
Applicants: Lead applicant Lovestone (Ballard co-PI)

Duration: 2014-2017
Funding agency: Parkinson’s UK
Name: Proteomics: Finding biomarkers for Parkinson's
Costs: £749,888
Applicants: Lead applicant Lovestone (Ballard co-PI)

Key publications | Publications by category | Publications by year

Publications by category


Books

Burns A, Ballard C, Banerjee S, Calabrese P, De Deyn PP, Grossberg G, Jones R, Sandman PO, Selmes J, Vellas B, et al (2005). The clinical use of memantine. Abstract.

Journal articles

Ballard C, Mobley W, Hardy J, Williams G, Corbett A (In Press). Dementia in Down's syndrome. Lancet Neurol, 15(6), 622-636. Abstract.  Author URL.
Surr CA, Walwyn REA, Lilley-Kelly A, Cicero R, Meads D, Ballard C, Burton K, Chenoweth L, Corbett A, Creese B, et al (In Press). Evaluating the effectiveness and cost-effectiveness of Dementia Care Mapping™ to enable person-centred care for people with dementia and their carers (DCM-EPIC) in care homes: study protocol for a randomised controlled trial. Trials, 17(1). Abstract.  Author URL.  Full text.
Wesnes KA, Brooker H, Ballard C, McCambridge L, Stenton R, Corbett A (In Press). Utility, reliability, sensitivity and validity of an online test system designed to monitor changes in cognitive function in clinical trials. Int J Geriatr Psychiatry, 32(12), e83-e92. Abstract.  Author URL.  Full text.
Pickett J, Bird C, Ballard C, Banerjee S, Brayne C, Cowan K, Clare L, Comas-Herrera A, Corner L, Daley S, et al (2018). A roadmap to advance dementia research in prevention, diagnosis, intervention, and care by 2025. Int J Geriatr Psychiatry, 33(7), 900-906. Abstract.  Author URL.  Full text.
Ballard C, Lang I (2018). Alcohol and dementia: a complex relationship with potential for dementia prevention. The Lancet Public Health, 3(3), e103-e104.
Erdal A, Flo E, Aarsland D, Ballard C, Slettebo DD, Husebo BS (2018). Efficacy and Safety of Analgesic Treatment for Depression in People with Advanced Dementia: Randomised, Multicentre, Double-Blind, Placebo-Controlled Trial (DEP.PAIN.DEM). Drugs and Aging, 35(6), 545-558. Abstract.
Ballard C, Banister C, Khan Z, Cummings J, Demos G, Coate B, Youakim JM, Owen R, Stankovic S, Tomkinson EB, et al (2018). Evaluation of the safety, tolerability, and efficacy of pimavanserin versus placebo in patients with Alzheimer's disease psychosis: a phase 2, randomised, placebo-controlled, double-blind study. The Lancet Neurology, 17(3), 211-212. Abstract.
Petyaeva A, Kajander M, Lawrence V, Clifton L, Thomas AJ, Ballard C, Leroi I, Briggs M, Closs J, Dening T, et al (2018). Feasibility of a staff training and support programme to improve pain assessment and management in people with dementia living in care homes. Int J Geriatr Psychiatry, 33(1), 221-231. Abstract.  Author URL.
Creese B, Bell E, Johar I, Francis P, Ballard C, Aarsland D (2018). Glucocerebrosidase mutations and neuropsychiatric phenotypes in Parkinson's disease and Lewy body dementias: Review and meta-analyses. Am J Med Genet B Neuropsychiatr Genet, 177(2), 232-241. Abstract.  Author URL.
Mueller C, Perera G, Rajkumar AP, Bhattarai M, Price A, O'Brien JT, Ballard C, Stewart R, Aarsland D (2018). Hospitalization in people with dementia with Lewy bodies: Frequency, duration, and cost implications. Alzheimer's and Dementia: Diagnosis, Assessment and Disease Monitoring, 10, 143-152. Abstract.
Ballard C, Corbett A, Orrell M, Williams G, Moniz-Cook E, Romeo R, Woods B, Garrod L, Testad I, Woodward-Carlton B, et al (2018). Impact of person-centred care training and person-centred activities on quality of life, agitation, and antipsychotic use in people with dementia living in nursing homes: a cluster-randomised controlled trial. PLoS Med, 15(2). Abstract.  Author URL.
Huntley J, Corbett A, Wesnes K, Brooker H, Stenton R, Hampshire A, Ballard C (2018). Online assessment of risk factors for dementia and cognitive function in healthy adults. Int J Geriatr Psychiatry, 33(2), e286-e293. Abstract.  Author URL.
Bereczki E, Branca RM, Francis PT, Pereira JB, Baek JH, Hortobágyi T, Winblad B, Ballard C, Lehtiö J, Aarsland D, et al (2018). Synaptic markers of cognitive decline in neurodegenerative diseases: a proteomic approach. Brain, 141(2), 582-595. Abstract.
Ballard C, Testad I (2018). TIME in the Context of Emerging Evidence Regarding Training Interventions for Dementia in Nursing Homes. Am J Geriatr Psychiatry, 26(1), 39-41. Author URL.
Creese B, Da Silva MV, Johar I, Ballard C (2018). The modern role of antipsychotics for the treatment of agitation and psychosis in Alzheimer's disease. Expert Rev Neurother, 18(6), 461-467. Abstract.  Author URL.  Full text.
Erdal A, Flo E, Aarsland D, Selbaek G, Ballard C, Slettebo DD, Husebo BS (2018). Tolerability of buprenorphine transdermal system in nursing home patients with advanced dementia: a randomized, placebo-controlled trial (DEP.PAIN.DEM). Clinical Interventions in Aging, 13, 935-946. Abstract.
Skogseth R, Hortobágyi T, Soennesyn H, Chwiszczuk L, Ffytche D, Rongve A, Ballard C, Aarsland D (2017). Accuracy of clinical diagnosis of dementia with lewy bodies versus neuropathology. Journal of Alzheimer's Disease, 59(4), 1139-1152. Abstract.
Aarsland D, Creese B, Politis M, Chaudhuri KR, Ffytche DH, Weintraub D, Ballard C (2017). Cognitive decline in Parkinson disease. Nat Rev Neurol, 13(4), 217-231. Abstract.  Author URL.
Webster L, Groskreutz D, Grinbergs-Saull A, Howard R, O'Brien JT, Mountain G, Banerjee S, Woods B, Perneczky R, Lafortune L, et al (2017). Core outcome measures for interventions to prevent or slow the progress of dementia for people living with mild to moderate dementia: Systematic review and consensus recommendations. PLoS One, 12(6). Abstract.  Author URL.  Full text.
Knapp M, King D, Romeo R, Adams J, Baldwin A, Ballard C, Banerjee S, Barber R, Bentham P, Brown RG, et al (2017). Cost-effectiveness of donepezil and memantine in moderate to severe Alzheimer's disease (the DOMINO-AD trial). International Journal of Geriatric Psychiatry, 32(12), 1205-1216. Abstract.
Livingston G, Sommerlad A, Orgeta V, Costafreda SG, Huntley J, Ames D, Ballard C, Banerjee S, Burns A, Cohen-Mansfield J, et al (2017). Dementia prevention, intervention, and care. The Lancet, 390(10113), 2673-2734.
Webster L, Groskreutz D, Grinbergs-Saull A, Howard R, O'Brien JT, Mountain G, Banerjee S, Woods B, Perneczky R, Lafortune L, et al (2017). Development of a core outcome set for disease modification trials in mild to moderate dementia: a systematic review, patient and public consultation and consensus recommendations. Health Technol Assess, 21(26), 1-192. Abstract.  Author URL.  Full text.
McKeith IG, Boeve BF, Dickson DW, Halliday G, Taylor J-P, Weintraub D, Aarsland D, Galvin J, Attems J, Ballard CG, et al (2017). Diagnosis and management of dementia with Lewy bodies Fourth consensus report of the DLB Consortium. NEUROLOGY, 89(1), 88-100. Author URL.
Khan A, Corbett A, Ballard C (2017). Emerging amyloid and tau targeting treatments for Alzheimer's disease. Expert Rev Neurother, 17(7), 697-711. Abstract.  Author URL.
Khan A, Corbett A, Ballard C (2017). Emerging treatments for Alzheimer's disease for non-amyloid and non-tau targets. Expert Rev Neurother, 17(7), 683-695. Abstract.  Author URL.
Rajkumar AP, Ballard C, Fossey J, Orrell M, Moniz-Cook E, Woods RT, Murray J, Whitaker R, Stafford J, Knapp M, et al (2017). Epidemiology of Pain in People with Dementia Living in Care Homes: Longitudinal Course, Prevalence, and Treatment Implications. J Am Med Dir Assoc, 18(5), 453.e1-453.e6. Abstract.  Author URL.
Mueller C, Ballard C, Corbett A, Aarsland D (2017). Historical landmarks in dementia with Lewy bodies. Lancet Neurol, 16(5). Author URL.
Ballard C, Orrell M, Sun Y, Moniz-Cook E, Stafford J, Whitaker R, Woods B, Corbett A, Banerjee S, Testad I, et al (2017). Impact of antipsychotic review and non-pharmacological intervention on health-related quality of life in people with dementia living in care homes: WHELD-a factorial cluster randomised controlled trial. Int J Geriatr Psychiatry, 32(10), 1094-1103. Abstract.  Author URL.
Gatt A, Ekonomou A, Somani A, Thuret S, Howlett D, Corbett A, Johnson M, Perry E, Attems J, Francis P, et al (2017). Importance of Proactive Treatment of Depression in Lewy Body Dementias: the Impact on Hippocampal Neurogenesis and Cognition in a Post-Mortem Study. Dement Geriatr Cogn Disord, 44(5-6), 283-293. Abstract.  Author URL.
Chong JR, Chai YL, Lee JH, Howlett D, Attems J, Ballard CG, Aarsland D, Francis PT, Chen CP, Lai MKP, et al (2017). Increased transforming growth factor β2 in the neocortex of Alzheimer's disease and dementia with lewy bodies is correlated with disease severity and soluble Aβ<inf>42</inf>load. Journal of Alzheimer's Disease, 56(1), 157-166. Abstract.
Bath PM, Scutt P, Blackburn DJ, Ankolekar S, Krishnan K, Ballard C, Burns A, Mant J, Passmore P, Pocock S, et al (2017). Intensive versus Guideline Blood Pressure and Lipid Lowering in Patients with Previous Stroke: Main results from the pilot prevention of Decline in Cognition after Stroke trial' (PODCAST) randomised controlled trial. PLoS ONE, 12(1). Abstract.
Chai YL, Xing H, Chong JR, Francis PT, Ballard CG, Chen CP, Lai MKP (2017). Mitochondrial Translocase of the Outer Membrane Alterations May Underlie Dysfunctional Oxidative Phosphorylation in Alzheimer's Disease. Journal of Alzheimer's Disease, 61(2), 793-801. Abstract.
Lanctôt KL, Amatniek J, Ancoli-Israel S, Arnold SE, Ballard C, Cohen-Mansfield J, Ismail Z, Lyketsos C, Miller DS, Musiek E, et al (2017). Neuropsychiatric signs and symptoms of Alzheimer's disease: New treatment paradigms. Alzheimer's and Dementia: Translational Research and Clinical Interventions, 3(3), 440-449. Abstract.
Velayudhan L, Ffytche D, Ballard C, Aarsland D (2017). New Therapeutic Strategies for Lewy Body Dementias. Current Neurology and Neuroscience Reports, 17(9). Abstract.
Hammond SP, Cross JL, Shepstone L, Backhouse T, Henderson C, Poland F, Sims E, MacLullich A, Penhale B, Howard R, et al (2017). PERFECTED enhanced recovery (PERFECT-ER) care versus standard acute care for patients admitted to acute settings with hip fracture identified as experiencing confusion: study protocol for a feasibility cluster randomized controlled trial. Trials, 18(1). Abstract.  Author URL.
Alghamdi A, Vallortigara J, Howlett DR, Broadstock M, Hortobágyi T, Ballard C, Thomas AJ, O'Brien JT, Aarsland D, Attems J, et al (2017). Reduction of RPT6/S8 (a Proteasome Component) and Proteasome Activity in the Cortex is Associated with Cognitive Impairment in Lewy Body Dementia. J Alzheimers Dis, 57(2), 373-386. Abstract.  Author URL.
Ffytche DH, Pereira JB, Ballard C, Chaudhuri KR, Weintraub D, Aarsland D (2017). Risk factors for early psychosis in PD: Insights from the Parkinson's Progression markers initiative. Journal of Neurology, Neurosurgery and Psychiatry, 88(4), 325-331. Abstract.
Romeo R, Knapp M, Salverda S, Orrell M, Fossey J, Ballard C (2017). The cost of care homes for people with dementia in England: a modelling approach. International Journal of Geriatric Psychiatry, 32(12), 1466-1475. Abstract.
Mueller C, Ballard C, Corbett A, Aarsland D (2017). The prognosis of dementia with Lewy bodies. Lancet Neurol, 16(5), 390-398. Abstract.  Author URL.
Ffytche DH, Creese B, Politis M, Chaudhuri KR, Weintraub D, Ballard C, Aarsland D (2017). The psychosis spectrum in Parkinson disease. Nat Rev Neurol, 13(2), 81-95. Abstract.  Author URL.
Greenan C, Murphy L, Yu LM, Kehoe PG, Coulthard E, Bath P, Stewart R, Jones R, Corbett A, Thomas A, et al (2016). A randomised controlled trial of calcium channel blockade (CCB) with Amlodipine for the treatment oF subcortical ischaEmic vasCular demenTia (AFFECT): Study protocol. Trials, 17(1). Abstract.  Full text.
Enache D, Fereshtehnejad SM, Kï reholt I, Cermakova P, Garcia-Ptacek S, Johnell K, Religa D, Jelic V, Winblad B, Ballard C, et al (2016). Antidepressants and mortality risk in a dementia cohort: data from SveDem, the Swedish Dementia Registry. Acta Psychiatrica Scandinavica, 134(5), 430-440. Abstract.
Selbæk G, Aarsland D, Ballard C, Engedal K, Langballe EM, Benth JŠ, Bergh S (2016). Antipsychotic Drug Use is Not Associated with Long-Term Mortality Risk in Norwegian Nursing Home Patients. Journal of the American Medical Directors Association, 17(5), 464.e1-464.e7. Abstract.
Rajkumar AP, Ballard C, Fossey J, Corbett A, Woods B, Orrell M, Prakash R, Moniz-Cook E, Testad I (2016). Apathy and its Response to Antipsychotic Review and Nonpharmacological Interventions in People with Dementia Living in Nursing Homes: WHELD, a Factorial Cluster Randomized Controlled Trial. Journal of the American Medical Directors Association, 17(8), 741-747. Abstract.
Lovestone S, Rossor M, Gallacher J, Ritchie C, Burn D, Hyslop PSG, Mackay C, Matthews PM, Ballard C, Georges J, et al (2016). Better together for better dementia research and care. The Lancet Psychiatry, 3(6), 503-504.
Rongve A, Soennesyn H, Skogseth R, Oesterhus R, Hortobágyi T, Ballard C, Auestad BH, Aarsland D (2016). Cognitive decline in dementia with Lewy bodies: a 5-year prospective cohort study. BMJ Open, 6(2). Abstract.
Winblad B, Amouyel P, Andrieu S, Ballard C, Brayne C, Brodaty H, Cedazo-Minguez A, Dubois B, Edvardsson D, Feldman H, et al (2016). Defeating Alzheimer's disease and other dementias: a priority for European science and society. The Lancet Neurology, 15(5), 455-532.
Gatt AP, Duncan OF, Attems J, Francis PT, Ballard CG, Bateman JM (2016). Dementia in Parkinson's disease is associated with enhanced mitochondrial complex I deficiency. Movement Disorders, 31(3), 352-359. Abstract.
Corbett A, Ballard C (2016). Dextromethorphan and quinidine are suitable for off-label short-term treatment of agitation in people with Alzheimer's disease following first-line non-drug approaches. Evid Based Med, 21(1). Author URL.
Winblad B, Qiu C, Ballard C, Johansson G (2016). Evidence-based prevention and treatment of dementia – Authors' reply. The Lancet Neurology, 15(10), 1007-1008.
Brooker DJ, Latham I, Evans SC, Jacobson N, Perry W, Bray J, Ballard C, Fossey J, Pickett J (2016). FITS into practice: Translating research into practice in reducing the use of anti-psychotic medication for people with dementia living in care homes. Aging and Mental Health, 20(7), 709-718. Abstract.
Lawrence V, Fossey J, Ballard C, Ferreira N, Murray J (2016). Helping staff to implement psychosocial interventions in care homes: Augmenting existing practices and meeting needs for support. International Journal of Geriatric Psychiatry, 31(3), 284-293. Abstract.
Ballard C, Orrell M, YongZhong S, Moniz-Cook E, Stafford J, Whittaker R, Woods B, Corbett A, Garrod L, Khan Z, et al (2016). Impact of Antipsychotic Review and Nonpharmacological Intervention on Antipsychotic Use, Neuropsychiatric Symptoms, and Mortality in People with Dementia Living in Nursing Homes: a Factorial Cluster-Randomized Controlled Trial by the Well-Being and Health for People with Dementia (WHELD) Program. Am J Psychiatry, 173(3), 252-262. Abstract.  Author URL.
Xing H, Lim YA, Chong JR, Lee JH, Aarsland D, Ballard CG, Francis PT, Chen CP, Lai MKP (2016). Increased phosphorylation of collapsin response mediator protein-2 at Thr514 correlates with β-amyloid burden and synaptic deficits in Lewy body dementias. Molecular Brain, 9(1). Abstract.
Lee JH, Francis PT, Ballard CG, Aarsland D, Kalaria RN, Wong PTH, Chen CP, Lai MKP (2016). Muscarinic M1 Receptor Coupling to G-protein is Intact in Parkinson's Disease Dementia. Journal of Parkinson's Disease, 6(4), 733-739. Abstract.
Rongve A, Ballard C, Aarsland D (2016). Non-Alzheimer Dementias. Journal of Geriatric Psychiatry and Neurology, 29(5), 247-248.
Aman Y, Pitcher T, Simeoli R, Ballard C, Malcangio M (2016). Reduced thermal sensitivity and increased opioidergic tone in the TASTPM mouse model of Alzheimer's disease. Pain, 157(10), 2285-2296. Abstract.
Bereczki E, Francis PT, Howlett D, Pereira JB, Höglund K, Bogstedt A, Cedazo-Minguez A, Baek JH, Hortobágyi T, Attems J, et al (2016). Synaptic proteins predict cognitive decline in Alzheimer's disease and Lewy body dementia. Alzheimer's and Dementia, 12(11), 1149-1158. Abstract.
Sultana J, Fontana A, Giorgianni F, Pasqua A, Cricelli C, Spina E, Gambassi G, Ivanovic J, Ferrajolo C, Molokhia M, et al (2016). The Effect of Safety Warnings on Antipsychotic Drug Prescribing in Elderly Persons with Dementia in the United Kingdom and Italy: a Population-Based Study. CNS Drugs, 30(11), 1097-1109. Abstract.
Baek JH, Whitfield D, Howlett D, Francis P, Bereczki E, Ballard C, Hortobágyi T, Attems J, Aarsland D (2016). Unfolded protein response is activated in Lewy body dementias. Neuropathology and Applied Neurobiology, 42(4), 352-365. Abstract.
Khan A, Kalaria RN, Corbett A, Ballard C (2016). Update on Vascular Dementia. J Geriatr Psychiatry Neurol, 29(5), 281-301. Abstract.  Author URL.
Ballard C, Thomas A, Gerry S, Yu L-M, Aarsland D, Merritt C, Corbett A, Davison C, Sharma N, Khan Z, et al (2015). A Double-Blind Randomized Placebo-Controlled Withdrawal Trial Comparing Memantine and Antipsychotics for the Long-Term Treatment of Function and Neuropsychiatric Symptoms in People with Alzheimer's Disease (MAIN-AD). JOURNAL OF THE AMERICAN MEDICAL DIRECTORS ASSOCIATION, 16(4), 316-322. Author URL.
Zuidema SU, Johansson A, Selbaek G, Murray M, Burns A, Ballard C, Koopmans RTCM (2015). A consensus guideline for antipsychotic drug use for dementia in care homes. Bridging the gap between scientific evidence and clinical practice. International Psychogeriatrics, 27(11), 1849-1859. Abstract.
Puangmalai N, Somani A, Thangnipon W, Ballard C, Broadstock M (2015). A genetically immortalized human stem cell line: a promising new tool for Alzheimer’s disease therapy. EXCLI Journal, 14, 1135-1144. Abstract.
Livingston G, Frankish H (2015). A global perspective on dementia care: a Lancet Commission. The Lancet, 386(9997), 933-934.
Ferreira N, Owen A, Mohan A, Corbett A, Ballard C (2015). Associations between cognitively stimulating leisure activities, cognitive function and age-related cognitive decline. INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY, 30(4), 422-430. Author URL.
Scutt P, Blackburn D, Krishnan K, Ballard C, Burns A, Ford GA, Mant J, Passmore P, Pocock S, Reckless J, et al (2015). Baseline characteristics, analysis plan and report on feasibility for the Prevention of Decline in Cognition After Stroke Trial (PODCAST). Trials, 16(1). Abstract.
Husebo BS, Flo E, Aarsland D, Selbaek G, Testad I, Gulla C, Aasmul I, Ballard C (2015). COSMOS--improving the quality of life in nursing home patients: protocol for an effectiveness-implementation cluster randomized clinical hybrid trial. Implement Sci, 10 Abstract.  Author URL.
Vallortigara J, Whitfield D, Quelch W, Alghamdi A, Howlett D, Hortobágyi T, Johnson M, Attems J, O'Brien JT, Thomas A, et al (2015). Decreased Levels of VAMP2 and Monomeric Alpha-Synuclein Correlate with Duration of Dementia. Journal of Alzheimer's Disease, 50(1), 101-110. Abstract.
Whitfield DR, Vallortigara J, Alghamdi A, Hortobágyi T, Ballard C, Thomas AJ, O'Brien JT, Aarsland D, Francis PT (2015). Depression and synaptic zinc regulation in alzheimer disease, dementia with lewy bodies, and parkinson disease dementia. American Journal of Geriatric Psychiatry, 23(2), 141-148. Abstract.
Green D, Ballard C, Kunst G (2015). Depth of anaesthesia optimisation and postoperative cognitive dysfunction. British Journal of Anaesthesia, 114(2), 343-344.
Ballard C, Sharp S, Corbett A (2015). Dextromethorphan and Quinidine for Treating Agitation in Patients with Alzheimer Disease Dementia. JAMA, 314(12), 1233-1235. Author URL.
Corbett A, Williams G, Ballard C (2015). Drug repositioning in Alzheimer's disease. Front Biosci (Schol Ed), 7, 184-188. Abstract.  Author URL.
Creese B, Corbett A, DPhil EJ, Fox C, Ballard C (2015). Erratum to [Role of the Extended MAPT Haplotype in the Worsening of Psychotic Symptoms and Treatment Response in Alzheimer Disease, J Am Med Dir Assoc, 15, 12, (2014), 934-937], DOI: 10.1016/j.jamda.2014.08.011. Journal of the American Medical Directors Association, 16(3).
Ballard C, Isaacson S, Mills R, Williams H, Corbett A, Coate B, Pahwa R, Rascol O, Burn DJ (2015). Impact of Current Antipsychotic Medications on Comparative Mortality and Adverse Events in People with Parkinson Disease Psychosis. J Am Med Dir Assoc, 16(10), 898.e1-898.e7. Abstract.  Author URL.
Enache D, Cavallin L, Lindberg O, Farahmand B, Kramberger MG, Westman E, Jelic V, Eriksdotter M, Ballard C, Winblad B, et al (2015). Medial temporal lobe atrophy and depressive symptoms in elderly patients with and without alzheimer disease. Journal of Geriatric Psychiatry and Neurology, 28(1), 40-48. Abstract.
Soto M, Andrieu S, Nourhashemi F, Ousset PJ, Ballard C, Robert P, Vellas B, Lyketsos CG, Rosenberg PB (2015). Medication development for agitation and aggression in Alzheimer disease: Review and discussion of recent randomized clinical trial design. International Psychogeriatrics, 27(2), 181-197. Abstract.
Wesnes KA, Aarsland D, Ballard C, Londos E (2015). Memantine improves attention and episodic memory in Parkinson's disease dementia and dementia with Lewy bodies. Int J Geriatr Psychiatry, 30(1), 46-54. Abstract.  Author URL.
Howard R, McShane R, Lindesay J, Ritchie C, Baldwin A, Barber R, Burns A, Dening T, Findlay D, Holmes C, et al (2015). Nursing home placement in the Donepezil and Memantine in Moderate to Severe Alzheimer's Disease (DOMINO-AD) trial: Secondary and post-hoc analyses. The Lancet Neurology, 14(12), 1171-1181. Abstract.
Howlett DR, Whitfield D, Johnson M, Attems J, O'Brien JT, Aarsland D, Lai MKP, Lee JH, Chen C, Ballard C, et al (2015). Regional Multiple Pathology Scores Are Associated with Cognitive Decline in Lewy Body Dementias. Brain Pathology, 25(4), 401-408. Abstract.
Ekonomou A, Savva GM, Brayne C, Forster G, Francis PT, Johnson M, Perry EK, Attems J, Somani A, Minger SL, et al (2015). Stage-specific changes in neurogenic and glial markers in Alzheimer's disease. Biological Psychiatry, 77(8), 711-719. Abstract.
Bradley P, Akehurst R, Ballard C, Banerjee S, Blennow K, Bremner J, Broich K, Cummings J, Dening K, Dubois B, et al (2015). Taking stock: a multistakeholder perspective on improving the delivery of care and the development of treatments for Alzheimer's disease. Alzheimer's and Dementia, 11(4), 455-461. Abstract.
Corbett A, Owen A, Hampshire A, Grahn J, Stenton R, Dajani S, Burns A, Howard R, Williams N, Williams G, et al (2015). The Effect of an Online Cognitive Training Package in Healthy Older Adults: an Online Randomized Controlled Trial. Journal of the American Medical Directors Association, 16(11), 990-997. Author URL.
Ballard C, Corbett A, Sharp S (2014). Aligning the evidence with practice: NICE guidelines for drug treatment of Alzheimer’s disease. Expert Review of Neurotherapeutics, 11(3), 327-329.
Whitfield DR, Vallortigara J, Alghamdi A, Howlett D, Hortobágyi T, Johnson M, Attems J, Newhouse S, Ballard C, Thomas AJ, et al (2014). Assessment of ZnT3 and PSD95 protein levels in Lewy body dementias and Alzheimer's disease: Association with cognitive impairment. Neurobiology of Aging, 35(12), 2836-2844. Abstract.
Sultana J, Chang CK, Hayes RD, Broadbent M, Stewart R, Corbett A, Ballard C (2014). Associations between risk of mortality and atypical antipsychotic use in vascular dementia: a clinical cohort study. International Journal of Geriatric Psychiatry, 29(12), 1249-1254.
Creese B, Ballard C, Aarsland D, Londos E, Sharp S, Jones E (2014). Corrigendum to "No association of COMT val158met polymorphism and psychotic symptoms in Lewy body dementias" [Neurosci. Lett. 531 (1) (2012) 1-4]. Neuroscience Letters, 580
Gatt AP, Jones EL, Francis PT, Ballard C, Bateman JM (2014). Corrigendum to Association of a polymorphism in mitochondrial transcription factor a (TFAM) with Parkinson's disease dementia but not dementia with Lewy bodies [Neurosci. Lett. 557, (2013), 177-180]. Neuroscience Letters, 563
Lebedev AV, Beyer MK, Fritze F, Westman E, Ballard C, Aarsland D (2014). Cortical changes associated with depression and antidepressant use in alzheimer and lewy body dementia: an MRI surface-based morphometric study. American Journal of Geriatric Psychiatry, 22(1). Abstract.
Stewart R, Hotopf M, Dewey M, Ballard C, Bisla J, Calem M, Fahmy V, Hockley J, Kinley J, Pearce H, et al (2014). Current prevalence of dementia, depression and behavioural problems in the older adult care home sector: the South East London care home survey. Age and Ageing, 43(4), 562-567. Abstract.
Mohamed NE, Howlett DR, Ma L, Francis PT, Aarsland D, Ballard CG, McKeith IG, Chen CP, Lai MKP (2014). Decreased immunoreactivities of neocortical AMPA receptor subunits correlate with motor disability in Lewy body dementias. Journal of Neural Transmission, 121(1), 71-78. Abstract.
Creese B, Ballard C, Aarsland D, Londos E, Sharp S, Jones E (2014). Determining the Association of the 5HTTLPR Polymorphism with Delusions and Hallucinations in Lewy Body Dementias. The American Journal of Geriatric Psychiatry, 22(6), 580-586.
Corbett A, Burns A, Ballard C (2014). Don't use antipsychotics routinely to treat agitation and aggression in people with dementia. BMJ, 349 Author URL.
Mulugeta E, Vallortigara J, Francis PT, Hye A, Kalaria RN, Perry EK, Lovestone S, Ballard CG (2014). Dynamin protein in stroke and vascular dementia. Neuroscience Letters, 563, 118-122. Abstract.
Vallortigara J, Rangarajan S, Whitfield D, Alghamdi A, Howlett D, Hortobágyi T, Johnson M, Attems J, Ballard C, Thomas A, et al (2014). Dynamin1 concentration in the prefrontal cortex is associated with cognitive impairment in Lewy body dementia. F1000Research, 3 Abstract.
Husebo BS, Ballard C, Fritze F, Sandvik RK, Aarsland D (2014). Efficacy of pain treatment on mood syndrome in patients with dementia: a randomized clinical trial. International Journal of Geriatric Psychiatry, 29(8), 828-836. Abstract.
Ruiz A, Hernández I, Ronsende-Roca M, González-Pérez A, Rodriguez-Noriega E, Ramírez-Lorca R, Mauleón A, Moreno-Rey C, Boswell L, Tune L, et al (2014). Erratum to "Exploratory analysis of seven Alzheimer's disease genes: Disease progression" [Neurobiol. Aging 34, (2013), 1310.e1-1310.e7], doi:10.1016/j.neurobiolaging.2012.08.014. Neurobiology of Aging, 35(11).
Mok KY, Jones EL, Hanney M, Harold D, Sims R, Williams J, Ballard C, Hardy J (2014). Erratum to "Polymorphisms in BACE2 may affect the age of onset Alzheimer's dementia in Down syndrome" [Neurobiol. Aging 35 (2014) 1513.e1-1513.e5]. Neurobiology of Aging, 35(12).
Mok KY, Jones EL, Hanney M, Harold D, Sims R, Williams J, Ballard C, Hardy J (2014). Erratum to "Polymorphisms in BACE2 may affect the age of onset Alzheimer's dementia in Down syndrome" [Neurobiol. Aging 35, (2014), 1513.e1-1513.e5], doi:10.1016/j.neurobiolaging.2013.12.022. Neurobiology of Aging, 35(11).
Ballard C, Aarsland D, Francis P, Corbett A (2014). Erratum to: Neuropsychiatric symptoms in patients with dementias associated with cortical Lewy bodies: Pathophysiology, clinical features, and pharmacological management (Drugs Aging (2013) 30, (603-611) DOI: 10.1007/s40266-013-0092-x). Drugs and Aging, 31(8).
Lawrence V, Pickett J, Ballard C, Murray J (2014). Erratum: Patient and carer views on participating in clinical trials for prodromal Alzheimer's disease and mild cognitive impairment. International Journal of Geriatric Psychiatry, 29(12).
Testad I, Corbett A, Aarsland D, Lexow KO, Fossey J, Woods B, Ballard C (2014). Erratum: the value of personalized psychosocial interventions to address behavioral and psychological symptoms in people with dementia living in care home settings: a systematic review (International Psychogeriatrics (2014) DOI; 10.1017/S1041610214000131)). International Psychogeriatrics, 26(7).
Wimo A, Ballard C, Brayne C, Gauthier S, Handels R, Jones RW, Jonsson L, Khachaturian AS, Kramberger M (2014). Health economic evaluation of treatments for Alzheimer′s disease: Impact of new diagnostic criteria. Journal of Internal Medicine, 275(3), 304-316. Abstract.
Sandvik RK, Selbaek G, Seifert R, Aarsland D, Ballard C, Corbett A, Husebo BS (2014). Impact of a stepwise protocol for treating pain on pain intensity in nursing home patients with dementia: a cluster randomized trial. Eur J Pain, 18(10), 1490-1500. Abstract.  Author URL.
Whitaker R, Fossey J, Ballard C, Orrell M, Moniz-Cook E, Woods RT, Murray J, Stafford J, Knapp M, Romeo R, et al (2014). Improving Well-being and Health for People with Dementia (WHELD): study protocol for a randomised controlled trial. Trials, 15 Abstract.  Author URL.
Broadstock M, Ballard C, Corbett A (2014). Latest treatment options for Alzheimer's disease, Parkinson's disease dementia and dementia with Lewy bodies. Expert Opin Pharmacother, 15(13), 1797-1810. Abstract.  Author URL.
Oesterhus R, Soennesyn H, Rongve A, Ballard C, Aarsland D, Vossius C (2014). Long-term mortality in a Cohort of home-dwelling elderly with mild Alzheimer's disease and Lewy body dementia. Dementia and Geriatric Cognitive Disorders, 38(3-4), 161-169. Abstract.
Corbett A, Smith J, Ballard C (2014). New and emerging treatments for Alzheimer’s disease. Expert Review of Neurotherapeutics, 12(5), 535-543.
Broadstock M, Ballard C, Corbett A (2014). Novel pharmaceuticals in the treatment of psychosis in Parkinson's disease. Expert Rev Clin Pharmacol, 7(6), 779-786. Abstract.  Author URL.
Lawrence V, Pickett J, Ballard C, Murray J (2014). Patient and carer views on participating in clinical trials for prodromal Alzheimer's disease and mild cognitive impairment. International Journal of Geriatric Psychiatry, 29(1), 22-31. Abstract.
Cummings J, Isaacson S, Mills R, Williams H, Chi-Burris K, Corbett A, Dhall R, Ballard C (2014). Pimavanserin for patients with Parkinson's disease psychosis: a randomised, placebo-controlled phase 3 trial. Lancet, 383(9916), 533-540. Abstract.  Author URL.
Mok KY, Jones EL, Hanney M, Harold D, Sims R, Williams J, Ballard C, Hardy J (2014). Polymorphisms in BACE2 may affect the age of onset Alzheimer's dementia in Down syndrome. Neurobiology of Aging, 35(6). Abstract.
Ballard C, Corbett A, Howard R (2014). Prescription of antipsychotics in people with dementia. Br J Psychiatry, 205(1), 4-5. Author URL.
Ballard C, Francis P, Corbett A (2014). Randomized controlled trial of mibampator for behavioral and psychological symptoms of dementia: comments on the trial and thoughts for future studies - ADDENDUM. Int Psychogeriatr Author URL.
Creese B, Corbett A, Jones E, Fox C, Ballard C (2014). Role of the Extended MAPT Haplotype in the Worsening of Psychotic Symptoms and Treatment Response in Alzheimer Disease. Journal of the American Medical Directors Association, 15(12), 934-937.
Ballard C, Corbett A (2014). Screening for dementia: an opportunity for debate. Expert Review of Neurotherapeutics, 11(10), 1347-1349.
Langballe EM, Engdahl B, Nordeng H, Ballard C, Aarsland D, Selbæk G (2014). Short- and long-term mortality risk associated with the use of antipsychotics among 26,940 dementia outpatients: a population-based study. American Journal of Geriatric Psychiatry, 22(4), 321-331. Abstract.
Fossey J, Masson S, Stafford J, Lawrence V, Corbett A, Ballard C (2014). The disconnect between evidence and practice: a systematic review of person-centred interventions and training manuals for care home staff working with people with dementia. INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY, 29(8), 797-807. Author URL.
Marshall MR, Ballard CE, Frogbrook ZL, Solloway I, Mcintyre N, Reynolds B, Wheater HS (2014). The impact of rural land management changes on soil hydraulic properties and runoff processes: Results from experimental plots in upland UK. Hydrological Processes, 28(4), 2617-2629. Abstract.
Husebo BS, Ballard C, Cohen-Mansfield J, Seifert R, Aarsland D (2014). The response of agitated behavior to pain management in persons with dementia. American Journal of Geriatric Psychiatry, 22(7), 708-717. Abstract.
Testad I, Corbett A, Aarsland D, Lexow KO, Fossey J, Woods B, Ballard C (2014). The value of personalized psychosocial interventions to address behavioral and psychological symptoms in people with dementia living in care home settings: a systematic review. INTERNATIONAL PSYCHOGERIATRICS, 26(7), 1083-1098. Author URL.
Corbett A, Ballard C (2014). The value of vitamin E as a treatment for Alzheimer's disease remains unproven despite functional improvement, due to a lack of established effect on cognition or other outcomes from RCTs. Evidence Based Medicine, 19(4), 140-140.
Stubendorff K, Larsson V, Ballard C, Minthon L, Aarsland D, Londos E (2014). Treatment effect of memantine on survival in dementia with Lewy bodies and Parkinson's disease with dementia: a prospective study. BMJ Open, 4(7). Abstract.
Siepel FJ, Rongve A, Buter TC, Beyer MK, Ballard CG, Booij J, Aarsland D (2013). (123I)FP-CIT SPECT in suspected dementia with Lewy bodies: a longitudinal case study. BMJ Open, 3(4). Abstract.
Nordberg A, Ballard C, Bullock R, Darreh-Shori T, Somogyi M (2013). A review of butyrylcholinesterase as a therapeutic target in the treatment of Alzheimer's disease. Primary Care Companion to the Journal of Clinical Psychiatry, 15(2). Abstract.
Ballard C, Corbett A (2013). Agitation and aggression in people with Alzheimerʼs disease. Current Opinion in Psychiatry, 26(3), 252-259.
Ballard C, O'Sullivan MJ (2013). Alzheimer disease and stroke: Cognitive and neuroimaging predictors of AD and stroke. Nature Reviews Neurology, 9(11), 605-606.
Jones EL, Gauge N, Nilsen OB, Lowery D, Wesnes K, Katsaiti E, Arden J, Amoako D, Prophet N, Purushothaman B, et al (2013). Analysis of neuron-specific enolase and S100B as biomarkers of cognitive decline following surgery in older people. Dementia and Geriatric Cognitive Disorders, 34(5-6), 307-311. Abstract.
Corbett A, Husebo B, Malcangio M, Staniland A, Cohen-Mansfield J, Aarsland D, Ballard C (2013). Assessment and treatment of pain in people with dementia. Nature Reviews Neurology, 9(7), 358-358.
Gatt AP, Jones EL, Francis PT, Ballard C, Bateman JM (2013). Association of a polymorphism in mitochondrial transcription factor a (TFAM) with Parkinson's disease dementia but not dementia with Lewy bodies. Neuroscience Letters, 557(PB), 177-180. Abstract.
Creese B, Ballard C, Jones E (2013). Cognitive Impairment in Studies of 5HTTLPR and Psychosis in Alzheimer’s Disease: a Systematic Review. Dementia and Geriatric Cognitive Disorders, 35(3-4), 155-164.
Romeo R, Knapp M, Hellier J, Dewey M, Ballard C, Baldwin R, Bentham P, Burns A, Fox C, Holmes C, et al (2013). Cost-effectiveness analyses for mirtazapine and sertraline in dementia: Randomised controlled trial. British Journal of Psychiatry, 202(2), 121-128. Abstract.
Corbett A, Williams G, Ballard C (2013). Drug Repositioning: an Opportunity to Develop Novel Treatments for Alzheimer’s Disease. Pharmaceuticals, 6(10), 1304-1321.
Corbett A, Smith J, Ballard C (2013). Erratum: New and emerging treatments for Alzheimer's disease (Expert Review of Neurotherapeutics (2012) 12:5 (533-543) DOI: 10.1586/ern.12.43). Expert Review of Neurotherapeutics, 13(7).
Corbett A, Smith J, Ballard C (2013). Erratum: New and emerging treatments for Alzheimer's disease (Expert Review of Neurotherapeutics (2012) 12:5 (535-543)). Expert Review of Neurotherapeutics, 13(6).
Bajic N, Jenner P, Ballard CG, Francis PT (2013). Erratum: Proteasome inhibition leads to early loss of synaptic proteins in neuronal culture (Journal of Neural Transmission (2012) 119 (1467-1476) DOI:10.1007/s00702-012-0816-9). Journal of Neural Transmission, 120(7).
Jones EL, Mok K, Hanney M, Harold D, Sims R, Williams J, Ballard C (2013). Evidence that PICALM affects age at onset of alzheimer's dementia in down syndrome. Neurobiology of Aging, 34(10). Abstract.
Ruiz A, Hernández I, Ronsende-Roca M, González-Pérez A, Rodriguez-Noriega E, Ramírez-Lorca R, Mauleón A, Moreno-Rey C, Boswell L, Tune L, et al (2013). Exploratory analysis of seven Alzheimer's disease genes: Disease progression. Neurobiology of Aging, 34(4). Abstract.
Whitaker R, Ballard C, Stafford J, Orrell M, Moniz-Cook E, Woods RT, Murray J, Knapp M, Carlton BW, Fossey J, et al (2013). Feasibility study of an optimised person-centred intervention to improve mental health and reduce antipsychotics amongst people with dementia in care homes: Study protocol for a randomised controlled trial. Trials, 14(1). Abstract.
Ballard C, Grimmer T (2013). Improving diagnosis of possible DLB: is there a role for MIBG myocardial scintigraphy?. Neurology, 81(20), 1730-1731.
Corbett A, Ballard C (2013). Is a potential Alzheimer's therapy already in use for other conditions? can medications for hypertension, diabetes and acne help with the symptoms?. Expert Opinion on Investigational Drugs, 22(8), 941-943.
Ballard C, Roversi P, Walden H (2013). Molecular replacements. Acta Crystallographica Section D: Biological Crystallography, 69(11), 2165-2166.
Ballard C, Aarsland D, Francis P, Corbett A (2013). Neuropsychiatric Symptoms in Patients with Dementias Associated with Cortical Lewy Bodies: Pathophysiology, Clinical Features, and Pharmacological Management. Drugs & Aging, 30(8), 603-611.
Geda YE, Schneider LS, Gitlin LN, Miller DS, Smith GS, Bell J, Evans J, Lee M, Porsteinsson A, Lanctôt KL, et al (2013). Neuropsychiatric symptoms in Alzheimer's disease: Past progress and anticipation of the future. Alzheimer's and Dementia, 9(5), 602-608. Abstract.
Blackburn DJ, Krishnan K, Fox L, Ballard C, Burns A, Ford GA, Mant J, Passmore P, Pocock S, Reckless J, et al (2013). Prevention of Decline in Cognition after Stroke Trial (PODCAST): a study protocol for a factorial randomised controlled trial of intensive versus guideline lowering of blood pressure and lipids. Trials, 14(1). Abstract.
Ballard C, Corbett A (2013). Randomised controlled trial: a small proportion of people with dementia and neuropsychiatric symptoms experience clinically significant worsening when antidepressants are discontinued (Evidence-Based Medicine (2013) 18, (27-28)). Evidence-Based Medicine, 18(3).
Ballard C, Francis P, Corbett A (2013). Randomized controlled trial of mibampator for behavioral and psychological symptoms of dementia: comments on the trial and thoughts for future studies. International Psychogeriatrics, 25(05), 687-689.
Corbett A, Francis P, Ballard C (2013). Safety and efficacy of memantine extended-release in the management of alzheimer's disease. Clinical Medicine Insights: Therapeutics, 5, 95-102. Abstract.
Banerjee S, Hellier J, Romeo R, Dewey M, Knapp M, Ballard C, Baldwin R, Bentham P, Fox C, Holmes C, et al (2013). Study of the use of antidepressants for depression in dementia: the HTA-SADD trial- a multicentre, randomised, double-blind, placebo-controlled trial of the clinical effectiveness and cost-effectiveness of sertraline and mirtazapine. Health Technology Assessment, 17(7), 1-43. Abstract.
Husebo BS, Ballard C, Cohen-Mansfield J, Seifert R, Aarsland D (2013). The Response of Agitated Behavior to Pain Management in Persons with Dementia. American Journal of Geriatric Psychiatry
Jones EL, Aarsland D, Londos E, Ballard C (2012). A pilot study examining associations between DYRK1A and α-synuclein dementias. Neurodegenerative Diseases, 10(1-4), 229-231. Abstract.
Ballard C, Corbett A (2012). A small proportion of people with dementia and neuropsychiatric symptoms experience clinically significant worsening when antidepressants are discontinued. Evidence Based Medicine, 18(1), 27-28.
Corbett A, Ballard C (2012). Antipsychotics and Mortality in Dementia. American Journal of Psychiatry, 169(1), 7-9.
Corbett A, Husebo B, Malcangio M, Staniland A, Cohen-Mansfield J, Aarsland D, Ballard C (2012). Assessment and treatment of pain in people with dementia. Nature Reviews Neurology, 8(5), 264-274. Abstract.
Aarsland D, Ballard CG (2012). Biomarkers for dementia diagnosis: Differentiating DLB and FTD may be difficult. Journal of Neurology, Neurosurgery and Psychiatry, 83(11).
Aarsland D, Ballard C, Rongve A, Broadstock M, Svenningsson P (2012). Clinical trials of dementia with lewy bodies and parkinson's disease dementia. Current Neurology and Neuroscience Reports, 12(5), 492-501. Abstract.
Svenningsson P, Westman E, Ballard C, Aarsland D (2012). Cognitive impairment in patients with Parkinson's disease: Diagnosis, biomarkers, and treatment. The Lancet Neurology, 11(8), 697-707. Abstract.
Ballard C, Corbett A (2012). Dementia: New guidelines on disorders associated with dementia. Nature Reviews Neurology, 8(12), 663-664.
Aarsland D, Påhlhagen S, Ballard CG, Ehrt U, Svenningsson P (2012). Depression in Parkinson disease - Epidemiology, mechanisms and management. Nature Reviews Neurology, 8(1), 35-47. Abstract.
Howard R, McShane R, Lindesay J, Ritchie C, Baldwin A, Barber R, Burns A, Dening T, Findlay D, Holmes C, et al (2012). Donepezil and memantine for moderate-to-severe Alzheimer's disease. New England Journal of Medicine, 366(10), 893-903. Abstract.
Corbett A, Pickett J, Burns A, Corcoran J, Dunnett SB, Edison P, Hagan JJ, Holmes C, Jones E, Katona C, et al (2012). Drug repositioning for Alzheimer's disease. Nature Reviews Drug Discovery, 11(11), 833-846.
Ballard CE, McIntyre N, Wheater HS (2012). Effects of peatland drainage management on peak flows. Hydrology and Earth System Sciences, 16(7), 2299-2310. Abstract.
Fox C, Crugel M, Maidment I, Auestad BH, Coulton S, Treloar A, Ballard C, Boustani M, Katona C, Livingston G, et al (2012). Efficacy of memantine for agitation in Alzheimer's dementia: a randomised double-blind placebo controlled trial. PLoS ONE, 7(5). Abstract.
Lawrence V, Fossey J, Ballard C, Moniz-Cook E, Murray J (2012). Improving quality of life for people with dementia in care homes: Making psychosocial interventions work. British Journal of Psychiatry, 201(5), 344-351. Abstract.
Ekonomou A, Johnson M, Perry RH, Perry EK, Kalaria RN, Minger SL, Ballard CG (2012). Increased neural progenitors in individuals with cerebral small vessel disease. Neuropathology and Applied Neurobiology, 38(4), 344-353. Abstract.
Bulygina N, Ballard C, McIntyre N, O'Donnell G, Wheater H (2012). Integrating different types of information into hydrological model parameter estimation: Application to ungauged catchments and land use scenario analysis. Water Resources Research, 48(6). Abstract.
Hanney M, Prasher V, Williams N, Jones EL, Aarsland D, Corbett A, Lawrence D, Yu L-M, Tyrer S, Francis PT, et al (2012). Memantine for dementia in adults older than 40 years with Down's syndrome (MEADOWS): a randomised, double-blind, placebo-controlled trial. LANCET, 379(9815), 528-536. Author URL.
Perry EK, Johnson M, Ekonomou A, Perry RH, Ballard C, Attems J (2012). Neurogenic abnormalities in Alzheimer's disease differ between stages of neurogenesis and are partly related to cholinergic pathology. Neurobiology of Disease, 47(2), 155-162. Abstract.
Bjoerke-Bertheussen J, Ehrt U, Rongve A, Ballard C, Aarsland D (2012). Neuropsychiatric symptoms in mild dementia with lewy bodies and alzheimer's disease. Dementia and Geriatric Cognitive Disorders, 34(1), 1-6. Abstract.
Corbett A, Ballard C (2012). New and emerging treatments for Alzheimer's disease. Expert Opin Emerg Drugs, 17(2), 147-156. Abstract.  Author URL.
Creese B, Ballard C, Aarsland D, Londos E, Sharp S, Jones E (2012). No association of COMT val158met polymorphism and psychotic symptoms in Lewy body dementias. Neuroscience Letters, 531(1), 1-4.
Ballard C, Jones E, Gauge N, Aarsland D, Nilsen OB, Saxby BK, Lowery D, Corbett A, Wesnes K, Katsaiti E, et al (2012). Optimised Anaesthesia to Reduce Post Operative Cognitive Decline (POCD) in Older Patients Undergoing Elective Surgery, a Randomised Controlled Trial. PLoS ONE, 7(6), e37410-e37410.
Bajic N, Jenner P, Ballard CG, Francis PT (2012). Proteasome inhibition leads to early loss of synaptic proteins in neuronal culture. Journal of Neural Transmission, 119(12), 1467-1476. Abstract.
Corbett A, Smith J, Creese B, Ballard C (2012). Treatment of Behavioral and Psychological Symptoms of Alzheimer’s Disease. Current Treatment Options in Neurology, 14(2), 113-125.
Burns A, Perry E, Holmes C, Francis P, Morris J, Howes MJR, Chazot P, Lees G, Ballard C (2011). A double-blind placebo-controlled randomized trial of melissa officinalis oil and donepezil for the treatment of agitation in Alzheimer's disease. Dementia and Geriatric Cognitive Disorders, 31(2), 158-164. Abstract.
Ballard C, Gauthier S, Corbett A, Brayne C, Aarsland D, Jones E (2011). Alzheimer's disease. LANCET, 377(9770), 1019-1031. Author URL.
Jones EL, Ballard CG, Prasher VP, Arno M, Tyrer S, Moore B, Hanney ML (2011). An intron 7 polymorphism in APP affects the age of onset of dementia in down syndrome. International Journal of Alzheimer's Disease Abstract.
Clarke NA, Hartmann T, Jones EL, Ballard CG, Francis PT (2011). Antipsychotic medication is associated with selective alterations in ventricular cerebrospinal fluid Aβ 40 and tau in patients with intractable unipolar depression. International Journal of Geriatric Psychiatry, 26(12), 1283-1291. Abstract.
Creese B, Ballard C, Corbett A, Aarsland D (2011). Atypical antipsychotics for the treatment of behavioral and psychological symptoms in dementia, with a particular focus on longer term outcomes and mortality. Expert Opinion on Drug Safety, 10, 35-43.
Aarsland D, Husebo B, Ballard C (2011). Authors' reply to McShane and Regnard. BMJ (Online), 343(7821).
Mulugeta E, Londos E, Ballard C, Alves G, Zetterberg H, Blennow K, Skogseth R, Minthon L, Aarsland D (2011). CSF amyloid β38 as a novel diagnostic marker for dementia with Lewy bodies. Journal of Neurology, Neurosurgery and Psychiatry, 82(2), 160-164. Abstract.
Mulugeta E, Londos E, Hansson O, Ballard C, Skogseth R, Minthon L, Blennow K, Zetterberg H, Aarsland D (2011). Cerebrospinal fluid levels of sAPPα and sAPPβ in Lewy body and Alzheimer's disease: Clinical and neurochemical correlates. International Journal of Alzheimer's Disease Abstract.
Ballard C, Corbett A, Jones EL (2011). Dementia: challenges and promising developments. The Lancet Neurology, 10(1), 7-9.
Ballard C, Corbett A, Pickett J (2011). Depression and dementia. Ment Health Today, 23-25. Author URL.
Fritze F, Ehrt U, Sønnesyn H, Kurz M, Hortobágyi T, Nore SP, Ballard C, Aarsland D (2011). Depression in mild dementia: Associations with diagnosis, APOE genotype and clinical features. International Journal of Geriatric Psychiatry, 26(10), 1054-1061. Abstract.
Fritze F, Ehrt U, Hortobagyi T, Ballard C, Aarsland D (2011). Depressive symptoms in Alzheimer's disease and lewy body dementia: a one-year follow-up study. Dementia and Geriatric Cognitive Disorders, 32(2), 143-149. Abstract.
Howard R, Phillips P, Johnson T, O'Brien J, Sheehan B, Lindesay J, Bentham P, Burns A, Ballard C, Holmes C, et al (2011). Determining the minimum clinically important differences for outcomes in the DOMINO trial. International Journal of Geriatric Psychiatry, 26(8), 812-817. Abstract.
Auning E, Rongve A, Fladby T, Booij J, Hortobágyi T, Siepel FJ, Ballard C, Aarsland D (2011). Early and presenting symptoms of dementia with Lewy bodies. Dementia and Geriatric Cognitive Disorders, 32(3), 202-208. Abstract.
Johansson C, Ballard C, Hansson O, Palmqvist S, Minthon L, Aarsland D, Londos E (2011). Efficacy of memantine in PDD and DLB: an extension study including washout and open-label treatment. International Journal of Geriatric Psychiatry, 26(2), 206-213. Abstract.
Husebo BS, Ballard C, Sandvik R, Nilsen OB, Aarsland D (2011). Efficacy of treating pain to reduce behavioural disturbances in residents of nursing homes with dementia: Cluster randomised clinical trial. BMJ, 343(7816). Abstract.
Jones EL, Kalaria RN, Sharp SI, O'Brien JT, Francis PT, Ballard CG (2011). Genetic associations of autopsy-confirmed vascular dementia subtypes. Dementia and Geriatric Cognitive Disorders, 31(4), 247-253. Abstract.
Ballard CE, McIntyre N, Wheater HS, Holden J, Wallage ZE (2011). Hydrological modelling of drained blanket peatland. Journal of Hydrology, 407(1-4), 81-93. Abstract.
Sharp SI, Aarsland D, Day S, Sønnesyn H, Ballard C (2011). Hypertension is a potential risk factor for vascular dementia: Systematic review. International Journal of Geriatric Psychiatry, 26(7), 661-669. Abstract.
Öhrfelt A, Zetterberg H, Andersson K, Persson R, Secic D, Brinkmalm G, Wallin A, Mulugeta E, Francis PT, Vanmechelen E, et al (2011). Identification of novel α-synuclein isoforms in human brain tissue by using an online NanoLC-ESI-FTICR-MS method. Neurochemical Research, 36(11), 2029-2042. Abstract.
Ekonomou A, Ballard CG, Pathmanaban ON, Perry RH, Perry EK, Kalaria RN, Minger SL (2011). Increased neural progenitors in vascular dementia. Neurobiology of Aging, 32(12), 2152-2161. Abstract.
Corbett A, Ballard C (2011). Information provision services in dementia care. International Journal of Older People Nursing, 6(3), 217-226.
Morris CM, Ballard CG, Allan L, Rowan E, Stephens S, Firbank M, Ford GA, Kenny RA, O'Brien JT, Kalaria RN, et al (2011). NOS3 gene rs1799983 polymorphism and incident dementia in elderly stroke survivors. Neurobiology of Aging, 32(3). Abstract.
Johnson M, Ekonomou A, Hobbs C, Ballard CG, Perry RH, Perry EK (2011). Neurogenic marker abnormalities in the hippocampus in dementia with Lewy bodies. Hippocampus, 21(10), 1126-1136. Abstract.
Ballard C, Khan Z, Clack H, Corbett A (2011). Nonpharmacological treatment of Alzheimer disease. Can J Psychiatry, 56(10), 589-595. Abstract.  Author URL.
Husebo BS, Ballard C, Aarsland D (2011). Pain treatment of agitation in patients with dementia: a systematic review. International Journal of Geriatric Psychiatry, 26(10), 1012-1018. Abstract.
Banerjee S, Hellier J, Dewey M, Romeo R, Ballard C, Baldwin R, Bentham P, Fox C, Holmes C, Katona C, et al (2011). Sertraline or mirtazapine for depression in dementia (HTA-SADD): a randomised, multicentre, double-blind, placebo-controlled trial. The Lancet, 378(9789), 403-411. Abstract.
Husebo BS, Ballard C, Sandvik R, Nilsen OB, Aarsland D (2011). Systematic pain management reduced agitation in nursing home residents with dementia. Annals of Internal Medicine, 155(10).
Corbett A, Stevens J, Aarsland D, Day S, Moniz-Cook E, Woods R, Brooker D, Ballard C (2011). Systematic review of services providing information and/or advice to people with dementia and/or their caregivers. International Journal of Geriatric Psychiatry, 27(6), 628-636.
Ballard C, Smith J, Husebo B, Aarsland D, Corbett A (2011). The role of pain treatment in managing the behavioural and psychological symptoms of dementia (BPSD). Int J Palliat Nurs, 17(9), 420-424. Author URL.
Ballard C, Kahn Z, Corbett A (2011). Treatment of dementia with Lewy bodies and Parkinson's disease dementia. Drugs Aging, 28(10), 769-777. Abstract.  Author URL.
Alves G, Brønnick K, Aarsland D, Blennow K, Zetterberg H, Ballard C, Kurz MW, Andreasson U, Tysnes OB, Larsen JP, et al (2010). CSF amyloid-β and tau proteins, and cognitive performance, in early and untreated Parkinson's Disease: the Norwegian ParkWest study. Journal of Neurology, Neurosurgery and Psychiatry, 81(10), 1080-1086. Abstract.
Ballard CG, Jones EL (2010). CSF α-synuclein as a diagnostic biomarker for Parkinson disease and related dementias. Neurology, 75(20), 1760-1761.
Rongve A, Brønnick K, Ballard C, Aarsland D (2010). Core and suggestive symptoms of dementia with lewy bodies cluster in persons with mild dementia. Dementia and Geriatric Cognitive Disorders, 29(4), 317-324. Abstract.
Ballard C, Corbett A (2010). Definitions, criteria and mechanisms for vascular and mixed dementia. Minerva Psichiatrica, 51(1), 1-8. Abstract.
Testad I, Mikkelsen A, Ballard C, Aarsland D (2010). Health and well-being in care staff and their relations to organizational and psychosocial factors, care staff and resident factors in nursing homes. Int J Geriatr Psychiatry, 25(8), 789-797. Abstract.  Author URL.
Aarsland D, Sardahaee FS, Anderssen S, Ballard C, Alzheimer's SSRG (2010). Is physical activity a potential preventive factor for vascular dementia? a systematic review. Aging & mental health, 14(4), 386-395. Abstract.
Gauthier S, Cummings J, Ballard C, Brodaty H, Grossberg G, Robert P, Lyketsos C (2010). Management of behavioral problems in Alzheimer's disease. International Psychogeriatrics, 22(3), 346-372. Abstract.
Ballard C, Corbett A (2010). Management of neuropsychiatric symptoms in people with dementia. CNS Drugs, 24(9), 729-739. Abstract.  Author URL.
Vernon AC, Ballard C, Modo M (2010). Neuroimaging for Lewy body disease: is the in vivo molecular imaging of ?-synuclein neuropathology required and feasible?. Brain Research Reviews, 65(1), 28-55. Abstract.
Testad I, Auer S, Mittelman M, Ballard C, Fossey J, Donabauer Y, Aarsland D (2010). Nursing home structure and association with agitation and use of psychotropic drugs in nursing home residents in three countries: Norway, Austria and England. Int J Geriatr Psychiatry, 25(7), 725-731. Abstract.  Author URL.
Owen AM, Hampshire A, Grahn JA, Stenton R, Dajani S, Burns AS, Howard RJ, Ballard CG (2010). Putting brain training to the test. Nature, 465(7299), 775-778. Abstract.
Lowery DP, Wesnes K, Brewster N, Ballard C (2010). Subtle deficits of attention after surgery: Quantifying indicators of sub syndrome delirium. International Journal of Geriatric Psychiatry, 25(10), 945-952. Abstract.
Larsson V, Aarsland D, Ballard C, Minthon L, Londos E (2010). The effect of memantine on sleep behaviour in dementia with Lewy bodies and Parkinson's disease dementia. International Journal of Geriatric Psychiatry, 25(10), 1030-1038. Abstract.
Testad I, Ballard C, Brønnick K, Aarsland D (2010). The effect of staff training on agitation and use of restraint in nursing home residents with dementia: a single-blind, randomized controlled trial. J Clin Psychiatry, 71(1), 80-86. Abstract.  Author URL.
Ehrt U, Broich K, Larsen JP, Ballard C, Aarsland D (2010). Use of drugs with anticholinergic effect and impact on cognition in Parkinson's disease: a cohort study. Journal of Neurology, Neurosurgery and Psychiatry, 81(2), 160-165. Abstract.
Kirvell SL, Elliott MS, Kalaria RN, Hortobágyi T, Ballard CG, Francis PT (2010). Vesicular glutamate transporter and cognition in stroke: a case-control autopsy study. Neurology, 75(20), 1803-1809. Abstract.
Ballard C (2010). Video decision support affects patients' care choices in dementia care planning. Evidence-Based Mental Health, 13(1).
Ballard C, Jones EL, Londos E, Minthon L, Francis P, Aarsland D (2010). α-synuclein antibodies recognize a protein present at lower levels in the CSF of patients with dementia with Lewy bodies. International Psychogeriatrics, 22(2), 321-327. Abstract.
Jones EL, Hanney M, Francis PT, Ballard CG (2009). Amyloid β concentrations in older people with Down syndrome and dementia. Neuroscience Letters, 451(2), 162-164. Abstract.
Ballard C (2009). Atypical antipsychotics fail to improve functioning or quality of life in people with Alzheimer's disease. Evidence-Based Mental Health, 12(1).
Ballard C, Brown R, Fossey J, Douglas S, Bradley P, Hancock J, James IA, Juszczak E, Bentham P, Burns A, et al (2009). Brief psychosocial therapy for the treatment of agitation in Aalzheimer disease (The CALM-AD trial). American Journal of Geriatric Psychiatry, 17(9), 726-733. Abstract.
Lane R, He Y, Morris C, Leverenz JB, Emre M, Ballard C (2009). BuChE-K and APOE epsilon4 allele frequencies in Lewy body dementias, and influence of genotype and hyperhomocysteinemia on cognitive decline. Mov Disord, 24(3), 392-400. Abstract.  Author URL.
Sharp SI, Francis PT, Elliott MSJ, Kalaria RN, Bajic N, Hortobagyi T, Ballard CG (2009). Choline acetyltransferase activity in vascular dementia and stroke. Dementia and Geriatric Cognitive Disorders, 28(3), 233-238. Abstract.
Chalmers KA, Wilcock GK, Vinters HV, Perry EK, Perry R, Ballard CG, Love S (2009). Cholinesterase inhibitors may increase phosphorylated tau in Alzheimer's disease. J Neurol, 256(5), 717-720. Abstract.  Author URL.
Jones R, Sheehan B, Phillips P, Juszczak E, Adams J, Baldwin A, Ballard C, Banerjee S, Barber B, Bentham P, et al (2009). DOMINO-AD protocol: Donepezil and memantine in moderate to severe Alzheimer's disease - a multicentre RCT. Trials, 10 Abstract.
Huang L, Abuhamdah S, Howes MJR, Dixon CL, Elliot MSJ, Ballard C, Holmes C, Burns A, Perry EK, Francis PT, et al (2009). Erratum: Pharmacological profile of essential oils derived from Lavandula angustifolia and Melissa officinalis with anti-agitation properties: Focus on ligand-gated channels (Journal of Pharmacy and Pharmacology (2008) 59 (1515-1522)). Journal of Pharmacy and Pharmacology, 61(2).
Sonnesyn H, Nilsen DW, Rongve A, Nore S, Ballard C, Tysnes OB, Aarsland D (2009). High prevalence of orthostatic hypotension in mild dementia. Dementia and Geriatric Cognitive Disorders, 28(4), 307-313. Abstract.
Allan LM, Ballard CG, Rowan EN, Kenny RA (2009). Incidence and prediction of falls in dementia: a prospective study in older people. PLoS ONE, 4(5). Abstract.
Elliott MSJ, Ballard CG, Kalaria RN, Perry R, Hortobágyi T, Francis PT (2009). Increased binding to 5-HT1A and 5-HT2A receptors is associated with large vessel infarction and relative preservation of cognition. Brain, 132(Pt 7), 1858-1865. Abstract.  Author URL.
Ballard C, Corbett A, Chitramohan R, Aarsland D (2009). Management of agitation and aggression associated with Alzheimerʼs disease: controversies and possible solutions. Current Opinion in Psychiatry, 22(6), 532-540.
Ballard CG, Gauthier S, Cummings JL, Brodaty H, Grossberg GT, Robert P, Lyketsos CG (2009). Management of agitation and aggression associated with alzheimer disease. Nature Reviews Neurology, 5(5), 245-255. Abstract.
Aarsland D, Ballard C, Walker Z, Bostrom F, Alves G, Kossakowski K, Leroi I, Pozo-Rodriguez F, Minthon L, Londos E, et al (2009). Memantine in patients with Parkinson's disease dementia or dementia with Lewy bodies: a double-blind, placebo-controlled, multicentre trial. The Lancet Neurology, 8(7), 613-618. Abstract.
Sabbagh MN, Adler CH, Lahti TJ, Connor DJ, Vedders L, Peterson LK, Caviness JN, Shill HA, Sue LI, Ziabreva I, et al (2009). Parkinson disease with dementia: Comparing patients with and without alzheimer pathology. Alzheimer Disease and Associated Disorders, 23(3), 295-297. Abstract.
Aarsland D, Londos E, Ballard C (2009). Parkinson's disease dementia and dementia with Lewy bodies: Different aspects of one entity. International Psychogeriatrics, 21(2), 216-219.
Ballard C, Aarsland D (2009). Person-centred care and care mapping in dementia. The Lancet Neurology, 8(4), 302-303.
Ballard C, Hanney ML, Theodoulou M, Douglas S, McShane R, Kossakowski K, Gill R, Juszczak E, Yu LM, Jacoby R, et al (2009). The dementia antipsychotic withdrawal trial (DART-AD): long-term follow-up of a randomised placebo-controlled trial. The Lancet Neurology, 8(2), 151-157. Abstract.
Ballard C, Margallo-Lana M, O'Brien JT, James I, Howard R, Fossey J (2009). Top cited papers in international psychogeriatrics: 6a. quality of life for people with dementia living in residential and nursing home care: the impact of performance on activities of daily living, behavioral and psychological symptoms, language skills, and psychotropic drugs. International Psychogeriatrics, 21(6), 1026-1028.
Ballard C, Lana MM, Theodoulou M, Douglas S, McShane R, Jacoby R, Kossakowski K, Yu LM, Juszczak E (2008). A randomised, blinded, placebo-controlled trial in dementia patients continuing or stopping neuroleptics (The DART-AD Trial). PLoS Medicine, 5(4), 0587-0599. Abstract.
Scholey AB, Tildesley NTJ, Ballard CG, Wesnes KA, Tasker A, Perry EK, Kennedy DO (2008). An extract of Salvia (sage) with anticholinesterase properties improves memory and attention in healthy older volunteers. Psychopharmacology (Berl), 198(1), 127-139. Abstract.  Author URL.
Tasker A, Ballard CG, Joachim C, Warden DR, Okello EJ, Perry RH, Khan N, Smith AD, Lehmann DJ, Perry EK, et al (2008). Butyrylcholinesterase K variant associated with higher enzyme activity in the temporal cortex of elderly patients. Neuroscience Letters, 442(3), 297-299. Abstract.
Ballard C, Fossey J (2008). Clinical management of dementia. Psychiatry, 7(2), 88-93. Abstract.
Sharp SI, Ballard CG, Ziabreva I, Piggott MA, Perry RH, Perry EK, Aarsland D, Ehrt U, Larsen JP, Francis PT, et al (2008). Cortical serotonin 1A receptor levels are associated with depression in patients with dementia with lewy bodies and Parkinson's disease dementia. Dementia and Geriatric Cognitive Disorders, 26(4), 330-338. Abstract.
Khan A, Ballard C (2008). Current approaches to potential amyloid-based Alzheimer's disease therapies: Defeating dementia. Biochemist, 30(5), 14-17. Abstract.
Aarsland D, Kurz M, Beyer M, Bronnick K, Piepenstock Nore S, Ballard C (2008). Early discriminatory diagnosis of dementia with Lewy bodies: the emerging role of CSF and imaging biomarkers. Dementia and Geriatric Cognitive Disorders, 25(3), 195-205. Abstract.
Ballard C, Sauter M, Scheltens P, He Y, Barkhof F, van Straaten ECW, van der Flier WM, Hsu C, Wu S, Lane R, et al (2008). Efficacy, safety and tolerability of rivastigmine capsules in patients with probable vascular dementia: the VantagE study. Current Medical Research and Opinion, 24(9), 2561-2574. Abstract.
Wood-Mitchell A, James IA, Waterworth A, Swann A, Ballard C (2008). Factors influencing the prescribing of medications by old age psychiatrists for behavioural and psychological symptoms of dementia: a qualitative study. Age and Ageing, 37(5), 547-552. Abstract.
Aarsland D, Rongve A, Piepenstock Nore S, Skogseth R, Skulstad S, Ehrt U, Hoprekstad D, Ballard C (2008). Frequency and case identification of dementia with Lewy bodies using the revised consensus criteria. Dementia and Geriatric Cognitive Disorders, 26(5), 445-452. Abstract.
Mulugeta E, Molina-Holgado F, Elliott MS, Hortobagyi T, Perry R, Kalaria RN, Ballard CG, Francis PT (2008). Inflammatory mediators in the frontal lobe of patients with mixed and vascular dementia. Dement Geriatr Cogn Disord, 25(3), 278-286. Abstract.  Author URL.
Wilcock GK, Ballard CG, Cooper JA, Loft H (2008). Memantine for agitation/aggression and psychosis in moderately severe to severe Alzheimer's disease: a pooled analysis of 3 studies. Journal of Clinical Psychiatry, 69(3), 341-348. Abstract.
Skogseth R, Mulugeta E, Ballard C, Rongve A, Nore S, Alves G, Aarsland D (2008). Neuropsychiatric correlates of cerebrospinal fluid biomarkers in Alzheimer's disease. Dementia and Geriatric Cognitive Disorders, 25(6), 559-563. Abstract.
Skogseth R, Mulugeta E, Jones E, Ballard C, Rongve A, Nore S, Alves G, Aarsland D (2008). Neuropsychiatric correlates of cerebrospinal fluid biomarkers in Alzheimer's disease (Dementia and Geriatric Cognitive Disorders (2008) 25, (559-563)). Dementia and Geriatric Cognitive Disorders, 26(3).
Ballard C, Day S, Sharp S, Wing G, Sorensen S (2008). Neuropsychiatric symptoms in dementia: Importance and treatment considerations. International Review of Psychiatry, 20(4), 396-404. Abstract.
Abuhamdah S, Huang L, Elliott MSJ, Howes MJR, Ballard C, Holmes C, Burns A, Perry EK, Francis PT, Lees G, et al (2008). Pharmacological profile of an essential oil derived from Melissa officinalis with anti-agitation properties: Focus on ligand-gated channels. Journal of Pharmacy and Pharmacology, 60(3), 377-384. Abstract.
Huang L, Abuhamdah S, Howes MJR, Elliot MSJ, Ballard C, Holmes C, Burns A, Perry EK, Francis PT, Lees G, et al (2008). Pharmacological profile of essential oils derived from Lavandula angustifolia and Melissa officinalis with anti-agitation properties: Focus on ligand-gated channels. Journal of Pharmacy and Pharmacology, 60(11), 1515-1522. Abstract.
MacInnes N, Iravani MM, Perry E, Piggott M, Perry R, Jenner P, Ballard C (2008). Proteasomal abnormalities in cortical Lewy body disease and the impact of proteasomal inhibition within cortical and cholinergic systems. J Neural Transm (Vienna), 115(6), 869-878. Abstract.  Author URL.
Lowery DP, Wesnes K, Brewster N, Ballard C (2008). Quantifying the association between computerised measures of attention and confusion assessment method defined delirium: a prospective study of older orthopaedic surgical patients, free of dementia. International Journal of Geriatric Psychiatry, 23(12), 1253-1260. Abstract.
Lane R, Feldman HH, Meyer J, He Y, Ferris SH, Nordberg A, Darreh-Shori T, Soininen H, Pirttilä T, Farlow MR, et al (2008). Synergistic effect of apolipoprotein E ε4 and butyrylcholinesterase K-variant on progression from mild cognitive impairment to Alzheimer's disease. Pharmacogenetics and Genomics, 18(4), 289-298. Abstract.
Jones EL, Margallo-Lana M, Prasher VP, Ballard CG (2008). The extended tau haplotype and the age of onset of dementia in Down syndrome. Dementia and Geriatric Cognitive Disorders, 26(3), 199-202. Abstract.
Andersson M, Hansson O, Minthon L, Ballard CG, Londos E (2008). The period of hypotension following orthostatic challenge is prolonged in dementia with Lewy bodies. International Journal of Geriatric Psychiatry, 23(2), 192-198. Abstract.
Sharp SI, Ballard CG, Chen CPLH, Francis PT (2007). Aggressive behavior and neuroleptic medication are associated with increased number of alpha1-adrenoceptors in patients with alzheimer disease. American Journal of Geriatric Psychiatry, 15(5), 435-437. Abstract.
Ballard C (2007). Agitation and Psychosis in Dementia. American Journal of Geriatric Psychiatry, 15(11), 913-917.
Ballard C, Fossey J, Sharp S (2007). Antipsychotics in patients with Alzheimer's disease - What is their clinical value?: Commentary. Nature Clinical Practice Neurology, 3(5), 248-249.
Allan LM, Ballard CG, Allen J, Murray A, Davidson AW, McKeith IG, Kenny RA (2007). Autonomic dysfunction in dementia. J Neurol Neurosurg Psychiatry, 78(7), 671-677. Abstract.  Author URL.
Ballard CG, Chalmers KA, Todd C, McKeith IG, O'Brien JT, Wilcock G, Love S, Perry EK (2007). Cholinesterase inhibitors reduce cortical Aβ in dementia with Lewy bodies. Neurology, 68(20), 1726-1729. Abstract.
Ballard C (2007). Decisions are based on flawed models. British Journal of Hospital Medicine, 68(2).
Howard RJ, Juszczak E, Ballard CG, Bentham P, Brown RG, Bullock R, Burns AS, Holmes C, Jacoby R, Johnson T, et al (2007). Donepezil for the treatment of agitation in Alzheimer's disease. New England Journal of Medicine, 357(14), 1382-1392. Abstract.
Robinson L, Hutchings D, Dickinson HO, Corner L, Beyer F, Finch T, Hughes J, Vanoli A, Ballard C, Bond J, et al (2007). Effectiveness and acceptability of non-pharmacological interventions to reduce wandering in dementia: a systematic review. International Journal of Geriatric Psychiatry, 22(1), 9-22. Abstract.
Minger SL, Ekonomou A, Carta EM, Chinoy A, Perry RH, Ballard CG (2007). Endogenous neurogenesis in the human brain following cerebral infarction. Regenerative Medicine, 2(1), 69-74. Abstract.
Rowan EN, Dickinson HO, Stephens S, Ballard C, Kalaria R, Anne Kenny R (2007). Homocysteine and post-stroke cognitive decline [7]. Age and Ageing, 36(3), 339-343.
Ziabreva I, Ballard C, Johnson M, Larsen JP, McKeith I, Perry R, Aarsland D, Perry E (2007). Loss of Musashi1 in Lewy body dementia associated with cholinergic deficit. Neuropathol Appl Neurobiol, 33(5), 586-590. Author URL.
Firbank MJ, Burton EJ, Barber R, Stephens S, Kenny RA, Ballard C, Kalaria RN, O'Brien JT (2007). Medial temporal atrophy rather than white matter hyperintensities predict cognitive decline in stroke survivors. Neurobiology of Aging, 28(11), 1664-1669. Abstract.
Ballard C, Clack H, Green D (2007). Postoperative cognitive decline, dementia and anaesthesia. British Journal of Hospital Medicine, 68(11), 576-577.
Aarsland D, Emre M, Lees A, Poewe W, Ballard C (2007). Practice Parameter: Evaluation and treatment of depression, psychosis, and dementia in Parkinson disease (an evidence-based review): Report of the Quality Standards Subcommittee of the American Academy of Neurology [5]. Neurology, 68(1).
Piggott MA, Ballard CG, Rowan E, Holmes C, McKeith IG, Jaros E, Perry RH, Perry EK (2007). Selective loss of dopamine D2 receptors in temporal cortex in dementia with Lewy bodies, association with cognitive decline. Synapse, 61(11), 903-911. Abstract.
Lowery DP, Wesnes K, Ballard CG (2007). Subtle attentional deficits in the absence of dementia are associated with an increased risk of post-operative delirium. Dementia and Geriatric Cognitive Disorders, 23(6), 390-394. Abstract.
Piggott MA, Ballard CG, Dickinson HO, McKeith IG, Perry RH, Perry EK (2007). Thalamic D<inf>2</inf> receptors in dementia with Lewy bodies, Parkinson's disease, and Parkinson's disease dementia. International Journal of Neuropsychopharmacology, 10(2), 231-244. Abstract.
Elliott MSJ, Abuhamdah S, Howes MJR, Lees G, Ballard CG, Holmes C, Burns A, Chazot PL, Perry EK, Francis PT, et al (2007). The essential oils from Melissa officinalis L. and Lavandula angustifolia Mill. as potential treatment for agitation in people with severe dementia. International Journal of Essential Oil Therapeutics, 1(4), 143-152. Abstract.
Ballard C, Sharp S, Fossey J (2007). Time to discontinuation similar for atypical antipsychotic drugs and placebo in people with Alzheimer's disease: Commentary. Evidence-Based Mental Health, 10(2).
Robinson L, Hutchings D, Corner L, Beyer F, Dickinson H, Vanoli A, Finch T, Hughes J, Ballard C, May C, et al (2006). A systematic literature review of the effectiveness of non-pharmacological interventions to prevent wandering in dementia and evaluation of the ethical implications and acceptability of their use. Health Technology Assessment, 10(26). Abstract.
Robinson L, Hutchings D, Corner L, Beyer F, Dickinson H, Vanoli A, Finch T, Hughes J, Ballard C, May C, et al (2006). A systematic literature review of the effectiveness of non-pharmacological interventions to prevent wandering in dementia and evaluation of the ethical implications and acceptability of their use. Health technology assessment (Winchester, England), 10(26). Abstract.
Ziabreva I, Perry E, Perry R, Minger SL, Ekonomou A, Przyborski S, Ballard C (2006). Altered neurogenesis in Alzheimer's disease. J Psychosom Res, 61(3), 311-316. Abstract.  Author URL.
Ballard C, Lane R, Barone P, Ferrara R, Tekin S (2006). Cardiac safety of rivastigmine in Lewy body and Parkinson's disease dementias. International Journal of Clinical Practice, 60(6), 639-645. Abstract.
Rongve A, Aarsland D, Ballard C (2006). Current perspectives in dementia with Lewy bodies. Aging Health, 2(3), 461-472. Abstract.
Sauer J, Ffytche DH, Ballard C, Brown RG, Howard R (2006). Differences between Alzheimer's disease and dementia with Lewy bodies: an fMRI study of task-related brain activity. Brain, 129(7), 1780-1788. Abstract.
Ballard C, Ziabreva I, Perry R, Larsen JP, O'Brien J, McKeith I, Perry E, Aarsland D (2006). Differences in neuropathologic characteristics across the Lewy body dementia spectrum. Neurology, 67(11), 1931-1934. Abstract.  Author URL.
Fossey J, Ballard C, Juszczak E, James I, Alder N, Jacoby R, Howard R (2006). Effect of enhanced psychosocial care on antipsychotic use in nursing home residents with severe dementia: Cluster randomised trial. British Medical Journal, 332(7544), 756-758. Abstract.
Ballard C, Fox C (2006). Effectiveness of collaborative care for elderly adults with Alzheimer's disease in primary care. Lancet Neurology, 5(8), 644-645.
Kurz MW, Schlitter AM, Larsen JP, Ballard C, Aarsland D (2006). Familial occurrence of dementia and Parkinsonism: a systematic review. Dementia and Geriatric Cognitive Disorders, 22(4), 288-295. Abstract.
Ziabreva I, Ballard CG, Aarsland D, Larsen JP, McKeith IG, Perry RH, Perry EK (2006). Lewy body disease: Thalamic cholinergic activity related to dementia and parkinsonism. Neurobiology of Aging, 27(3), 433-438. Abstract.
Ballard C, Howard R (2006). Neuroleptic drugs in dementia: Benefits and harm. Nature Reviews Neuroscience, 7(6), 492-500. Abstract.
Lewis H, Beher D, Cookson N, Oakley A, Piggott M, Morris CM, Jaros E, Perry R, Ince P, Kenny RA, et al (2006). Quantification of Alzheimer pathology in ageing and dementia: age-related accumulation of amyloid-beta(42) peptide in vascular dementia. Neuropathol Appl Neurobiol, 32(2), 103-118. Abstract.  Author URL.
Pimlott SL, Piggott M, Ballard C, McKeith I, Perry R, Kometa S, Owens J, Wyper D, Perry E (2006). Thalamic nicotinic receptors implicated in disturbed consciousness in dementia with Lewy bodies. Neurobiol Dis, 21(1), 50-56. Abstract.  Author URL.
Ballard C, Waite J (2006). The effectiveness of atypical antipsychotics for the treatment of aggression and psychosis in Alzheimer's disease. Cochrane database of systematic reviews (Online)(1). Abstract.
Allan L, McKeith I, Ballard C, Kenny RA (2006). The prevalence of autonomic symptoms in dementia and their association with physical activity, activities of daily living and quality of life. Dementia and Geriatric Cognitive Disorders, 22(3), 230-237. Abstract.
Perry E, Ziabreva I, Perry R, Aarsland D, Ballard C (2005). Absence of cholinergic deficits in "pure" vascular dementia. Neurology, 64(1), 132-133. Abstract.  Author URL.
Stephens S, Kenny RA, Rowan E, Kalaria RN, Bradbury M, Pearce R, Wesnes K, Ballard CG (2005). Association between mild vascular cognitive impairment and impaired activities of daily living in older stroke survivors without dementia. Journal of the American Geriatrics Society, 53(1), 103-107. Abstract.
Allan LM, Kerr SRJ, Ballard CG, Allen J, Murray A, McLaren AT, Kenny RA (2005). Autonomic function assessed by heart rate variability is normal in Alzheimer's disease and vascular dementia. Dement Geriatr Cogn Disord, 19(2-3), 140-144. Abstract.  Author URL.
McLaren A, Kerr S, Allan L, Steen IN, Ballard C, Allen J, Murray A, Kenny RA (2005). Autonomic function is impaired in elderly stroke survivors. Stroke, 36(5), 1026-1030. Abstract.  Author URL.
Tasker A, Perry EK, Ballard CG (2005). Butyrylcholinesterase: Impact on symptoms and progression of cognitive impairment. Expert Review of Neurotherapeutics, 5(1), 101-106. Abstract.
Thomas A, Ballard C, Kenny RA, O'Brien J, Oakley A, Kalaria R (2005). Correlation of entorhinal amyloid with memory in Alzheimer's and vascular but not Lewy body dementia. Dementia and Geriatric Cognitive Disorders, 19(2-3), 57-60. Abstract.
McKeith IG, Dickson DW, Lowe J, Emre M, O'Brien JT, Feldman H, Cummings J, Duda JE, Lippa C, Perry EK, et al (2005). Diagnosis and management of dementia with Lewy bodies: Third report of the DLB consortium. Neurology, 65(12), 1863-1872. Abstract.
Ballard C, Cream J (2005). Drugs used to relieve behavioral symptoms in people with dementia or an unacceptable chemical cosh?. International Psychogeriatrics, 17(1), 4-12. Abstract.
Robinson L, Hughes J, Daley S, Keady J, Ballard C, Volicer L (2005). End-of-life care and dementia. Reviews in Clinical Gerontology, 15(2), 135-148.
Rowan E, Morris CM, Stephens S, Ballard C, Dickinson H, Rao H, Saxby BK, McLaren AT, Kalaria RN, Kenny RA, et al (2005). Impact of hypertension and apolipoprotein E4 on poststroke cognition in subjects &gt;75 years of age. Stroke, 36(9), 1864-1868. Abstract.
Rowan E, Morris CM, Stephens S, Ballard C, Dickinson H, Rao H, Saxby BK, McLaren AT, Kalaria RN, Kenny RA, et al (2005). Impact of hypertension and apolipoprotein E4 on poststroke cognition in subjects > 75 years of age. STROKE, 36(9), 1864-1868. Author URL.
Teaktong T, Piggott MA, Mckeith IG, Perry RH, Ballard CG, Perry EK (2005). Muscarinic M2 and M4 receptors in anterior cingulate cortex: Relation to neuropsychiatric symptoms in dementia with Lewy bodies. Behavioural Brain Research, 161(2), 299-305. Abstract.
Sharp SI, Francis PT, Ballard CG (2005). Neurochemistry of severe dementia. Reviews in Clinical Gerontology, 15(2), 105-123.
Aarsland D, Perry R, Larsen JP, McKeith IG, O'Brien JT, Perry EK, Burn D, Ballard CG (2005). Neuroleptic sensitivity in Parkinson's disease and parkinsonian dementias. J Clin Psychiatry, 66(5), 633-637. Abstract.  Author URL.
Ballard CG, Perry RH, McKeith IG, Perry EK (2005). Neuroleptics are associated with more severe tangle pathology in dementia with Lewy bodies. International Journal of Geriatric Psychiatry, 20(9), 872-875. Abstract.
Aarsland D, Perry R, Brown A, Larsen JP, Ballard C (2005). Neuropathology of dementia in Parkinson's disease: a prospective, community-based study. Ann Neurol, 58(5), 773-776. Abstract.  Author URL.
Tildesley NTJ, Kennedy DO, Perry EK, Ballard CG, Wesnes KA, Scholey AB (2005). Positive modulation of mood and cognitive performance following administration of acute doses of Salvia lavandulaefolia essential oil to healthy young volunteers. Physiol Behav, 83(5), 699-709. Abstract.  Author URL.
Allan LM, Ballard CG, Burn DJ, Kenny RA (2005). Prevalence and severity of gait disorders in Alzheimer's and non-Alzheimer's dementias. Journal of the American Geriatrics Society, 53(10), 1681-1687. Abstract.
Purandare N, Ballard C, Burns A (2005). Preventing dementia. Advances in Psychiatric Treatment, 11(3), 176-183. Abstract.
Aarsland D, Sharp S, Ballard C (2005). Psychiatric and behavioral symptoms in Alzheimer's disease and other dementias: Etiology and management. Current Neurology and Neuroscience Reports, 5(5), 345-354. Abstract.
Ballard C, Margallo-Lana M, Juszczak E, Douglas S, Swann A, Thomas A, O'Brien J, Everratt A, Sadler S, Maddison C, et al (2005). Quetiapine and rivastigmine and cognitive decline in Alzheimer's disease: Randomised double blind placebo controlled trial. British Medical Journal, 330(7496), 874-877. Abstract.
Holmes C, Ballard C, Lehmann D, Smith AD, Beaumont H, Day IN, Khan MN, Lovestone S, McCulley M, Morris CM, et al (2005). Rate of progression of cognitive decline in Alzheimer's disease: Effect of butyrylcholinesterase K gene variation. Journal of Neurology, Neurosurgery and Psychiatry, 76(5), 640-643. Abstract.
Ballard C, Morris C, Kalaria R, McKeith I, Perry R, Perry E (2005). The k variant of the butyrylcholinesterase gene is associated with reduced phosphorylation of tau in dementia patients. Dement Geriatr Cogn Disord, 19(5-6), 357-360. Abstract.  Author URL.
Peters N, Opherk C, Danek A, Ballard C, Herzog J, Dichgans M (2005). The pattern of cognitive performance in CADASIL: a monogenic condition leading to subcortical ischemic vascular dementia. American Journal of Psychiatry, 162(11), 2078-2085. Abstract.
Ballard C (2005). When the drugs don't work - Or do they? [1]. British Journal of General Practice, 55(519).
Ballard CG, Thomas A, Fossey J, Lee L, Jacoby R, Lana MM, Bannister C, McShane R, Swann A, Juszczak E, et al (2004). A 3-month, randomized, placebo-controlled, neuroleptic discontinuation study in 100 people with dementia: the neuropsychiatric inventory median cutoff is a predictor of clinical outcome. Journal of Clinical Psychiatry, 65(1), 114-119. Abstract.
Cormack F, Gray A, Ballard C, Tovée MJ (2004). A failure of 'pop-out' in visual search tasks in dementia with Lewy Bodies as compared to Alzheimer's and Parkinson's disease. International Journal of Geriatric Psychiatry, 19(8), 763-772. Abstract.
Ballard CG, Morris CM, Rao H, O'Brien JT, Barber R, Stephens S, Rowan E, Gibson A, Kalaria RN, Kenny RA, et al (2004). APOE ε4 and cognitive decline in older stroke patients with early cognitive impairment. Neurology, 63(8), 1399-1402. Abstract.
Aarsland D, Ballard CG, Halliday G (2004). Are Parkinson's disease with dementia and dementia with Lewy bodies the same entity?. Journal of Geriatric Psychiatry and Neurology, 17(3), 137-145. Abstract.
Holmes C, Ballard C (2004). Aromatherapy in dementia. Advances in Psychiatric Treatment, 10(4), 296-300. Abstract.
Kenny RA, Shaw FE, O'Brien JT, Scheltens PH, Kalaria R, Ballard C (2004). Carotid sinus syndrome is common in dementia with Lewy bodies and correlates with deep white matter lesions. Journal of Neurology, Neurosurgery and Psychiatry, 75(7), 966-971. Abstract.
Madhani P, Hughes J, Ballard CG (2004). Cholinesterase ihibitors and the heart in old age [1]. Advances in Psychiatric Treatment, 10(5).
Ballard C, Fossey J (2004). Clinical management of dementia. Psychiatry, 3(12), 27-32. Abstract.
Ballard CG (2004). Definition and diagnosis of dementia with Lewy bodies. Dementia and Geriatric Cognitive Disorders, 17(SUPPL. 1), 15-24. Abstract.
Margallo-Lana M, Morris CM, Gibson AM, Tan AL, Kay DWK, Tyrer SP, Moore BP, Ballard CG (2004). Influence of the amyloid precursor protein locus on dementia in Down syndrome. Neurology, 62(11), 1996-1998. Abstract.
Ray M, Bohr I, McIntosh JM, Ballard C, McKeith I, Chalon S, Guilloteau D, Perry R, Perry E, Court JA, et al (2004). Involvement of alpha6/alpha3 neuronal nicotinic acetylcholine receptors in neuropsychiatric features of Dementia with Lewy bodies: [(125)I]-alpha-conotoxin MII binding in the thalamus and striatum. Neurosci Lett, 372(3), 220-225. Abstract.  Author URL.
Ballard CG, Burton EJ, Barber R, Stephens S, Kenny RA, Kalaria RN, O'Brien JT (2004). NINDS AIREN neuroimaging criteria do not distinguish stroke patients with and without dementia. Neurology, 63(6), 983-988. Abstract.
Ballard CG, Jacoby R, Del Ser T, Khan MN, Munoz DG, Holmes C, Nagy Z, Perry EK, Joachim C, Jaros E, et al (2004). Neuropathological Substrates of Psychiatric Symptoms in Prospectively Studied Patients with Autopsy-Confirmed Dementia with Lewy Bodies. American Journal of Psychiatry, 161(5), 843-849. Abstract.
Stephens S, Kenny RA, Rowan E, Allan L, Kalaria RN, Bradbury M, Ballard CG (2004). Neuropsychological characteristics of mild vascular cognitive impairment and dementia after stroke. International Journal of Geriatric Psychiatry, 19(11), 1053-1057. Abstract.
Douglas S, James I, Ballard C (2004). Non-pharmacological interventions in dementia. Advances in Psychiatric Treatment, 10(3), 171-179. Abstract.
Cormack F, Aarsland D, Ballard C, Tovée MJ (2004). Pentagon drawing and neuropsychological performance in Dementia with Lewy Bodies, Alzheimer's disease, Parkinson's disease and Parkinson's disease with dementia. International Journal of Geriatric Psychiatry, 19(4), 371-377. Abstract.
Aarsland D, Ballard C (2004). Psychiatric issues in non-Alzheimer dementias. Clinical Neuroscience Research, 3(6), 397-412. Abstract.
Burton EJ, Kenny RA, O'Brien J, Stephens S, Bradbury M, Rowan E, Kalaria R, Firbank M, Wesnes K, Ballard CG, et al (2004). White matter hyperintensities are associated with impairment of memory, attention, and global cognitive performance in older stroke patients. Stroke, 35(6), 1270-1275. Abstract.
Karas GB, Burton EJ, Rombouts SARB, Van Schijndel RA, O'Brien JT, Scheltens P, McKeith IG, Williams D, Ballard C, Barkhof F, et al (2003). A comprehensive study of gray matter loss in patients with Alzheimer's disease using optimized voxel-based morphometry. NeuroImage, 18(4), 895-907. Abstract.
Ballard C, Kalaria R, Kenny RA, Thomas A (2003). Alzheimer's disease - a vascular dementia?. Reviews in Clinical Gerontology, 13(1), 67-74.
Perry E, McKeith I, Ballard C (2003). Butyrylcholinesterase and progression of cognitive deficits in dementia with Lewy bodies. Neurology, 60(11), 1852-1853. Abstract.
Ballard CG, Perry EK (2003). Butyrylcholinesterase: Potential importance for the symptoms and progression of cognitive decline in people with dementia. Acta Neurologica Taiwanica, 12(3), 109-113. Abstract.
McLaren AT, Allen J, Murray A, Ballard CG, Kenny RA (2003). Cardiovascular effects of donepezil in patients with dementia. Dement Geriatr Cogn Disord, 15(4), 183-188. Abstract.  Author URL.
Margallo-Lana ML, Ballard C, Morris C, Kay D, Tyrer S, Moore B (2003). Cholinesterase inhibitors in the treatment of dementia. Int J Geriatr Psychiatry, 18(5), 458-459. Author URL.
Margallo-Lana ML, Ballard C, Morris C, Kay D, Tyrer S, Moore B (2003). Cognitive decline in Down syndrome. Arch Neurol, 60(7). Author URL.
McKeith IG, Burn DJ, Ballard CG, Collerton D, Jaros E, Morris CM, McLaren A, Perry EK, Perry R, Piggott MA, et al (2003). Dementia with Lewy bodies. Semin Clin Neuropsychiatry, 8(1), 46-57. Abstract.  Author URL.
Burton E, Ballard C, Stephens S, Kenny RA, Kalaria R, Barber R, O'Brien J (2003). Hyperintensities and fronto-subcortical atrophy on MRI are substrates of mild cognitive deficits after stroke. Dementia and Geriatric Cognitive Disorders, 16(2), 113-118. Abstract.
Potkins D, Myint P, Bannister C, Tadros G, Chithramohan R, Swann A, O'Brien J, Fossey J, George E, Ballard C, et al (2003). Language impairment in dementia: Impact on symptoms and care needs in residential homes. International Journal of Geriatric Psychiatry, 18(11), 1002-1006. Abstract.
Ballard C, Stephens S, Kenny RA, Kalaria R, Tovee M, O'Brien J (2003). Profile of neuropsychological deficits in older stroke survivors without dementia. Dementia and Geriatric Cognitive Disorders, 16(1), 52-56. Abstract.
Ballard C, Rowan E, Stephens S, Kalaria R, Kenny RA (2003). Prospective follow-up study between 3 and 15 months after stroke: Improvements and decline in cognitive function among dementia-free stroke survivors &gt;75 years of age. Stroke, 34(10), 2440-2444. Abstract.
O'Brien KK, Saxby BK, Ballard CG, Grace J, Harrington F, Ford GA, O'Brien JT, Swan AG, Fairbairn AF, Wesnes K, et al (2003). Regulation of attention and response to therapy in dementia by butyrylcholinesterase. Pharmacogenetics, 13(4), 231-239. Abstract.
Snowdon J, Ballard CG (2003). Reporting changes in scores on the Cohen-Mansfield agitation inventory subscales [2] (multiple letters). Journal of Clinical Psychiatry, 64(6).
Perry NSL, Bollen C, Perry EK, Ballard C (2003). Salvia for dementia therapy: Review of pharmacological activity and pilot tolerability clinical trial. Pharmacology Biochemistry and Behavior, 75(3), 651-659. Abstract.
Tildesley NTJ, Kennedy DO, Perry EK, Ballard CG, Savelev S, Wesnes KA, Scholey AB (2003). Salvia lavandulaefolia (Spanish sage) enhances memory in healthy young volunteers. Pharmacol Biochem Behav, 75(3), 669-674. Abstract.  Author URL.
O'Brien JT, Erkinjuntti T, Reisberg B, Roman G, Sawada T, Pantoni L, Bowler JV, Ballard C, DeCarli C, Gorelick PB, et al (2003). Vascular cognitive impairment. Lancet Neurology, 2(2), 89-98. Abstract.
Colloby SJ, Fenwick JD, Williams DE, Paling SM, Lobotesis K, Ballard C, McKeith I, O'Brien JT (2002). A comparison of<sup>99m</sup>Tc-HMPAO SPET changes in dementia with Lewy bodies and Alzheimer's disease using statistical parametric mapping. European Journal of Nuclear Medicine, 29(5), 615-622. Abstract.
Ballard C, Johnson M, Piggott M, Perry R, O'Brien J, Rowan E, Perry E, Lantos P, Cairns N, Holmes C, et al (2002). A positive association between 5HT re-uptake binding sites and depression in dementia with Lewy bodies. J Affect Disord, 69(1-3), 219-223. Abstract.  Author URL.
Ballard CG (2002). Advances in the treatment of Alzheimer's disease: benefits of dual cholinesterase inhibition. European neurology, 47(1), 64-70. Abstract.
Ford GA, Ballard C, Thomas SHL (2002). Anti-psychotic drug use in older people. Age and Ageing, 31(4), 225-226.
Ballard CG, O'Brien JT, Reichelt K, Perry EK (2002). Aromatherapy as a safe and effective treatment for the management of agitation in severe dementia: the results of a double-blind, placebo-controlled trial with Melissa. Journal of Clinical Psychiatry, 63(7), 553-558. Abstract.
Ballard C, Powell I, James I, Reichelt K, Myint P, Potkins D, Bannister C, Lana M, Howard R, O'Brien J, et al (2002). Can psychiatric liaison reduce neuroleptic use and reduce health service utilization for dementia patients residing in care facilities. International Journal of Geriatric Psychiatry, 17(2), 140-145. Abstract.
Swann A, Ballard C (2002). Casebook: assessing confusion. Practitioner, 246(1639).
Singleton AB, Wharton A, O'Brien KK, Walker MP, McKeith IG, Ballard CG, O'Brien J, Perry RH, Ince PG, Edwardson JA, et al (2002). Clinical and neuropathological correlates of apolipoprotein E genotype in dementia with Lewy bodies. Dementia and Geriatric Cognitive Disorders, 14(3-4), 167-175. Abstract.
Lowery K, Ballard C, Rodgers H, McLaren A, O'Brien J, Rowan E, Stephens S (2002). Cognitive decline in prospectively studied group of stroke survivors, with a particular emphasis on the &gt;75's. Age and Ageing, 31(SUPPL. 3), 24-27. Abstract.
Fossey J, Lee L, Ballard C (2002). Dementia Care Mapping as a research tool for measuring quality of life in care settings: Psychometric properties. International Journal of Geriatric Psychiatry, 17(11), 1064-1070. Abstract.
Ballard CG, Court JA, Piggott M, Johnson M, O'Brien J, McKeith I, Holmes C, Lantos P, Jaros E, Perry R, et al (2002). Disturbances of consciousness in dementia with Lewy bodies associated with alteration in nicotinic receptor binding in the temporal cortex. Conscious Cogn, 11(3), 461-474. Abstract.  Author URL.
Ballard CG, Aarsland D, McKeith I, O'Brien J, Gray A, Cormaak F, Burn D, Cassidy T, Starfeldt R, Larsen JP, et al (2002). Fluctuations in attention: PD dementia vs DLB with parkinsonism. Neurology, 59(11), 1714-1720. Abstract.
Thomas AJ, O'Brien JT, Davis S, Ballard C, Barber R, Kalaria RN, Perry RH (2002). Ischemic basis for deep white matter hyperintensities in major depression: a neuropathological study. Archives of General Psychiatry, 59(9), 785-792. Abstract.
Burton EJ, Karas G, Paling SM, Barber R, Williams ED, Ballard CG, McKeith IG, Scheltens P, Barkhof F, O'Brien JT, et al (2002). Patterns of cerebral atrophy in Dementia with Lewy bodies using voxel-based morphometry. NeuroImage, 17(2), 618-630. Abstract.
Ballard C, O'Brien J, Tovee M (2002). Qualitative performance characteristics differentiate dementia with Lewy bodies and Alzheimer's disease. Journal of Neurology Neurosurgery and Psychiatry, 72(5), 565-566. Abstract.
Burns A, Byrne J, Ballard C, Holmes C (2002). Sensory stimulation in dementia. British Medical Journal, 325(7376), 1312-1313.
Burns A, Byrne J, Ballard C, Holmes C (2002). Sensory stimulation in dementia - an effective option for managing behavioural problems. BRITISH MEDICAL JOURNAL, 325(7376), 1312-1313. Author URL.
Hussain RI, Ballard CG, Edwardson JA, Morris CM (2002). Transferrin gene polymorphism in Alzheimer's disease and dementia with Lewy bodies in humans. Neuroscience Letters, 317(1), 13-16. Abstract.
Barber R, McKeith I, Ballard C, O'Brien J (2002). Volumetric MRI study of the caudate nucleus in patients with dementia with Lewy bodies, Alzheimer's disease, and vascular dementia. Journal of Neurology Neurosurgery and Psychiatry, 72(3), 406-407. Abstract.
Ballard CG, Margallo-Lana M, Fossey J, Reichelt K, Myint P, Potkins D, O'Brien J (2001). A 1-year follow-up study of behavioral and psychological symptoms in dementia among people in care environments. Journal of Clinical Psychiatry, 62(8), 631-636. Abstract.
Aarsland D, Ballard C, Larsen JP, McKeith I (2001). A comparative study of psychiatric symptoms in dementia with Lewy bodies and Parkinson's disease with and without dementia. International Journal of Geriatric Psychiatry, 16(5), 528-536. Abstract.
Barber R, Mckeith IG, Ballard C, Gholkar A, O'brien JT (2001). A comparison of medial and lateral temporal lobe atrophy in dementia with Lewy bodies and Alzheimer's disease: Magnetic resonance imaging volumetric study. Dementia and Geriatric Cognitive Disorders, 12(3), 198-205. Abstract.
Ballard C, O'Brien J, Gray A, Cormack F, Ayre G, Rowan E, Thompson P, Bucks R, McKeith I, Walker M, et al (2001). Attention and fluctuating attention in patients with dementia with lewy bodies and alzheimer disease. Archives of Neurology, 58(6), 977-982. Abstract.
O'Brien J, Thomas A, Ballard C, Brown A, Ferrier N, Jaros E, Perry R (2001). Cognitive impairment in depression is not associated with neuropathologic evidence of increased vascular or Alzheimer-type pathology. Biol Psychiatry, 49(2), 130-136. Abstract.  Author URL.
Aarsland D, Ballard C, McKeith I, Perry RH, Larsen JP (2001). Comparison of extrapyramidal signs in dementia with Lewy bodies and Parkinson's disease. Journal of Neuropsychiatry and Clinical Neurosciences, 13(3), 374-379. Abstract.
Middelkoop HAM, Van Der Flier WM, Burton EJ, Lloyd AJ, Paling S, Barber R, Ballard C, McKeith IG, O'Brien JT (2001). Dementia with Lewy bodies and AD are not associated with occipital lobe atrophy on MRI. Neurology, 57(11), 2117-2120. Abstract.
Campbell S, Stephens S, Ballard C (2001). Dementia with Lewy bodies: Clinical features and treatment. Drugs and Aging, 18(6), 397-407. Abstract.
O'brien JT, Ballard CG (2001). Drugs for Alzheimer's disease: Cholinesterase inhibitors have passed NICE's hurdle. BMJ, 323(7305), 123-124.
Howard R, Ballard C, O'Brien J, Burns A (2001). Guidelines for the management of agitation in dementia. International Journal of Geriatric Psychiatry, 16(7), 714-717.
Jackson EJ, Rajah S, Morris C, Ballard C, Thomas AJ, O'Brien JT (2001). Is apolipoprotein e4 associated with cognitive decline in depression?. Int J Geriatr Psychiatry, 16(4), 436-437. Author URL.
Margallo-Lana M, Reichelt K, Hayes P, Lee L, Fossey J, O'Brien J, Ballard C (2001). Longitudinal comparison of depression, coping, and turnover among NHS and private sector staff caring for people with dementia. British Medical Journal, 322(7289), 769-770.
Kalaria RN, Ballard CG, Ince PG, Kenny RA, McKeith IG, Morris CM, O'Brien JT, Perry EK, Perry RH, Edwardson JA, et al (2001). Multiple substrates of late-onset dementia: Implications for brain protection. Novartis Foundation Symposium, 235, 49-65. Abstract.
Singleton AB, Gibson AM, McKeith IG, Ballard CG, Edwardson JA, Morris CM (2001). Nitric oxide synthase gene polymorphisms in Alzheimer's disease and dementia with Lewy bodies. Neuroscience Letters, 303(1), 33-36. Abstract.
Lobotesis K, Fenwick JD, Phipps A, Ryman A, Swann A, Ballard C, McKeith IG, O'Brien JT (2001). Occipital hypoperfusion on SPECT in dementia with Lewy bodies but not AD. Neurology, 56(5), 643-649. Abstract.
Margallo-Lana M, Swann A, O'Brien J, Fairbairn A, Reichelt K, Potkins D, Mynt P, Ballard C (2001). Prevalence and pharmacological management of behavioural and psychological symptoms amongst dementia sufferers living in care environments. International Journal of Geriatric Psychiatry, 16(1), 39-44. Abstract.
O'Brien JT, Paling S, Barber R, Williams ED, Ballard C, McKeith IG, Gholkar A, Crum WR, Rossor MN, Fox NC, et al (2001). Progressive brain atrophy on serial MRI in dementia with Lewy Bodies, AD, and vascular dementia. Neurology, 56(10), 1386-1388. Abstract.
Ballard C, Fossey J, Chithramohan R, Howard R, Burns A, Thompson P, Tadros G, Fairbairn A (2001). Quality of care in private sector and NHS facilities for people with dementia: Cross sectional survey. British Medical Journal, 323(7310), 426-427.
Ballard C, O'Brien J, James I, Mynt P, Lana M, Potkins D, Reichelt K, Lee L, Swann A, Fossey J, et al (2001). Quality of life for people with dementia living in residential and nursing home care: the impact of performance on activities of daily living, behavioral and psychological symptoms, language skills, and psychotropic drugs. International Psychogeriatrics, 13(1), 93-106. Abstract.
Kalaria RN, Ballard C (2001). Stroke and cognition. Current atherosclerosis reports, 3(4), 334-339. Abstract.
Grace J, Lee KK, Ballard C, Herbert M (2001). The Relationship between Post-Natal Depression, Somatization and Behaviour in Malaysian Women. Transcultural Psychiatry, 38(1), 27-34. Abstract.
Ballard C, Walker M, O'Brien J, Rowan E, McKeith I (2001). The characterisation and impact of 'fluctuating' cognition in dementia with Lewy bodies and Alzheimer's disease. International Journal of Geriatric Psychiatry, 16(5), 494-498. Abstract.
Ballard CG, O'Brien JT, Swann AG, Thompson P, Neill D, McKeith IG (2001). The natural history of psychosis and depression in dementia with Lewy bodies and Alzheimer's disease: Persistence and new cases over 1 year of follow-up. Journal of Clinical Psychiatry, 62(1), 46-49. Abstract.
Ballard C, O'Brien J, Morris CM, Barber R, Swann A, Neill D, McKeith I (2001). The progression of cognitive impairment in dementia with Lewy bodies, vascular dementia and Alzheimer's disease. International Journal of Geriatric Psychiatry, 16(5), 499-503. Abstract.
Court JA, Ballard CG, Piggott MA, Johnson M, O'Brien JT, Holmes C, Cairns N, Lantos P, Perry RH, Jaros E, et al (2001). Visual hallucinations are associated with lower αbungarotoxin binding in dementia with Lewy bodies. Pharmacology Biochemistry and Behavior, 70(4), 571-579. Abstract.
Ballard C, Neill D, O'Brien J, McKeith IG, Ince P, Perry R (2000). Anxiety, depression and psychosis in vascular dementia: prevalence and associations. J Affect Disord, 59(2), 97-106. Abstract.  Author URL.
Porter RJ, Lunn BS, Walker LLM, Gray JM, Ballard CG, O'Brien JT (2000). Cognitive deficit induced by acute tryptophan depletion in patients with Alzheimer's disease. American Journal of Psychiatry, 157(4), 638-640. Abstract.
Cormack FK, Tovee M, Ballard C (2000). Contrast sensitivity and visual acuity in patients with Alzheimer's disease. International Journal of Geriatric Psychiatry, 15(7), 614-620. Abstract.
Cormack FK, Tovee M, Ballard C (2000). Contrast sensitivity and visual acuity in patients with Alzheimer's disease. INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY, 15(7), 614-620. Author URL.
Ballard C, Piggott M, Johnson M, Cairns N, Perry R, McKeith I, Jaros E, O'Brien J, Holmes C, Perry E, et al (2000). Delusions associated with elevated muscarinic binding in dementia with Lewy bodies. Annals of Neurology, 48(6), 868-876. Abstract.
Ballard C, Piggott M, Johnson M, Cairns N, Perry R, McKeith I, Jaros E, O'Brien J, Holmes C, Perry E, et al (2000). Delusions associated with elevated muscarinic binding in dementia with Lewy bodies. Ann Neurol, 48(6), 868-876. Abstract.  Author URL.
Lowery K, Mynt P, Aisbett J, Dixon T, O'Brien J, Ballard C (2000). Depression in the carers of dementia sufferers: a comparison of the carers of patients suffering from dementia with Lewy Bodies and the carers of patients with Alzheimer's disease. Journal of Affective Disorders, 59(1), 61-65. Abstract.
Thomas AJ, Ferrier IN, Kalaria RN, Woodward SA, Ballard C, Oakley A, Perry RH, O'Brien JT (2000). Elevation in late-life depression of intercellular adhesion molecule-1 expression in the dorsolateral prefrontal cortex. American Journal of Psychiatry, 157(10), 1682-1684. Abstract.
Potkins D, Bradley S, Shrimanker J, O'Brien J, Swann A, Ballard C (2000). End of life treatment decisions in people with dementia: Carers' views and the factors which influence them. International Journal of Geriatric Psychiatry, 15(11), 1005-1008. Abstract.
Terao T, Ballard CG, McKeith IG (2000). Hallucinations in Alzheimer's disease and Charles Bonnet syndrome [12]. American Journal of Psychiatry, 157(12).
Gibson AM, Singleton AB, Smith G, Woodward R, McKeith IG, Perry RH, Ince PG, Ballard CG, Edwardson JA, Morris CM, et al (2000). Lack of association of the α2-macroglobulin locus on chromosome 12 in AD. Neurology, 54(2), 433-438. Abstract.
Barber R, Gholkar A, Scheltens P, Ballard C, McKeith IG, O'Brien JT (2000). MRI volumetric correlates of white matter lesions in dementia with Lewy bodies and Alzheimer's disease. International Journal of Geriatric Psychiatry, 15(10), 911-916. Abstract.
Barber R, Ballard C, McKeith IG, Gholkar A, O'Brien JT (2000). MRI volumetric study of dementia with Lewy bodies: a comparison with AD and vascular dementia. Neurology, 54(6), 1304-1309. Abstract.
O'Brien JT, Metcalfe S, Swann A, Hobson J, Jobst K, Ballard C, McKeith I, Gholkar A (2000). Medial temporal lobe width on CT scanning in Alzheimer's disease: Comparison with vascular dementia, depression and dementia with Lewy bodies. Dementia and Geriatric Cognitive Disorders, 11(2), 114-118. Abstract.
Ballard C, McKeith I, O'Brien J, Kalaria R, Jaros E, Ince P, Perry R (2000). Neuropathological substrates of dementia and depression in vascular dementia, with a particular focus on cases with small infarct volumes. Dement Geriatr Cogn Disord, 11(2), 59-65. Abstract.  Author URL.
Court JA, Piggott MA, Lloyd S, Cookson N, Ballard CG, McKeith IG, Perry RH, Perry EK (2000). Nicotine binding in human striatum: Elevation in schizophrenia and reductions in dementia with Lewy bodies, Parkinson's disease and Alzheimer's disease and in relation to neuroleptic medication. NEUROSCIENCE, 98(1), 79-87. Author URL.
Martin-Ruiz C, Court J, Lee M, Piggott M, Johnson M, Ballard C, Kalaria R, Perry R, Perry E (2000). Nicotinic receptors in dementia of Alzheimer, lewy body and vascular types. Acta Neurologica Scandinavica, Supplement, 102(176), 34-41. Abstract.
Ballard C, McLaren A, Morris C (2000). Non-Alzheimer dementias. CURRENT OPINION IN PSYCHIATRY, 13(4), 409-414. Author URL.
Ballard C, O'Brien J, Swann A, Neill D, Lantos P, Holmes C, Burn D, Ince P, Perry R, McKeith I, et al (2000). One year follow-up of parkinsonism in dementia with Lewy bodies. Dement Geriatr Cogn Disord, 11(4), 219-222. Abstract.  Author URL.
Singleton AB, Hall R, Ballard CG, Perry RH, Xuereb JH, Rubinsztein DC, Tysoe C, Matthews P, Cordell B, Kumar-Singh S, et al (2000). Pathology of early-onset Alzheimer's disease cases bearing the Thr113-114ins presenilin-1 mutation. Brain, 123(12), 2467-2474. Abstract.
Bartlett S, Shrimanker J, Ballard C (2000). Prevalence of abnormal eating amongst elderly people in residential care. International Journal of Geriatric Psychiatry, 15(3), 283-284.
McKeith IG, Ballard CG, Perry RH, Ince PG, O'Brien JT, Neill D, Lowery K, Jaros E, Barber R, Thompson P, et al (2000). Prospective validation of Consensus criteria for the diagnosis of dementia with Lewy bodies. Neurology, 54(5), 1050-1058. Abstract.
Walker MP, Ayre GA, Perry EK, Wesnes K, McKeith IG, Tovee M, Edwardson JA, Ballard CG (2000). Quantification and characterisation of fluctuating cognition in dementia with Lewy bodies and Alzheimer's disease. Dementia and Geriatric Cognitive Disorders, 11(6), 327-335. Abstract.
Walker MP, Ayre GA, Cummings JL, Wesnes K, McKeith IG, O'Brien JT, Ballard CG (2000). Quantifying fluctuation in dementia with Lewy bodies, Alzheimer's disease, and vascular dementia. Neurology, 54(8), 1616-1624. Abstract.
Walker MP, Ayre GA, Cummings JL, Wesnes K, McKeith IG, O'Brien JT, Ballard CG (2000). The clinician assessment of fluctuation and the one day fluctuation assessment scale: Two methods to assess fluctuating confusion in dementia. British Journal of Psychiatry, 177(SEPT), 252-256. Abstract.
Lowery K, Buri H, Ballard C (2000). What is the prevalence of environmental hazards in the homes of dementia sufferers and are they associated with falls. INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY, 15(10), 883-886. Author URL.
Lowery K, Buri H, Ballard C (2000). What is the prevalence of environmental hazards in the homes of dementia sufferers and are they associated with falls. International Journal of Geriatric Psychiatry, 15(10), 883-886. Abstract.
Walker MP, Ayre GA, Ashton CH, Marsh VR, Wesnes K, Perry EK, O'Brien JT, McKeith IG, Ballard CG (1999). A psychophysiological investigation of fluctuating consciousness in neurodegenerative dementias. Human Psychopharmacology, 14(7), 483-489. Abstract.
Bartlett S, Ballard C (1999). Antidepressants in the elderly: a review. Expert Opinion on Investigational Drugs, 8(1), 51-63. Abstract.
Barber R, Gholkar A, Scheltens P, Ballard C, McKeith IG, Morris CM, O'Brien JT (1999). Apolipoprotein E ε4 allele, temporal lobe atrophy, and white matter lesions in late-life dementias. Archives of Neurology, 56(8), 961-965. Abstract.
Chapman FM, Dickinson J, McKeith I, Ballard C (1999). Association among visual hallucinations, visual acuity, and specific eye pathologies in Alzheimer's disease: Treatment implications. American Journal of Psychiatry, 156(12), 1983-1985. Abstract.
McKeith IG, O'Brien JT, Ballard C (1999). Diagnosing dementia with lewy bodies. Lancet, 354(9186), 1227-1228.
Harvey GT, Hughes J, McKeith IG, Briel R, Ballard C, Gholkar A, Scheltens P, Perry RH, Ince P, O'Brien JT, et al (1999). Magnetic resonance imaging differences between dementia with Lewy bodies and Alzheimer's disease: a pilot study. Psychological Medicine, 29(1), 181-187. Abstract.
Barber R, Gholkar A, Scheltens P, Ballard C, McKeith IG, O'Brien JT (1999). Medial temporal lobe atrophy on MRI in dementia with Lewy bodies. Neurology, 52(6), 1153-1158. Abstract.
Court J, Spurden D, Lloyd S, McKeith I, Ballard C, Cairns N, Kerwin R, Perry R, Perry E (1999). Neuronal nicotinic receptors in dementia with Lewy bodies and schizophrenia: alpha-bungarotoxin and nicotine binding in the thalamus. J Neurochem, 73(4), 1590-1597. Abstract.  Author URL.
Ballard C, Walker M (1999). Neuropsychiatric aspects of Alzheimer's disease. Current psychiatry reports, 1(1), 49-60. Abstract.
Kalaria RN, Ballard C (1999). Overlap between pathology of Alzheimer disease and vascular dementia. Alzheimer Disease and Associated Disorders, 13(SUPPL. 3). Abstract.
Ballard C, Holmes C, McKeith I, Neill D, O'Brien J, Cairns N, Lantos P, Perry E, Ince P, Perry R, et al (1999). Psychiatric morbidity in dementia with Lewy bodies: a prospective clinical and neuropathological comparative study with Alzheimer's disease. Am J Psychiatry, 156(7), 1039-1045. Abstract.  Author URL.
Ballard C, Gray A, Ayre G (1999). Psychotic symptoms, aggression and restlessness in dementia. Revue Neurologique, 155(SUPPL. 4). Abstract.
Neill D, Curran MD, Middleton D, Mawhinney H, Edwardson JA, McKeith I, Ballard C, Morris C, Ince P, Jaros E, et al (1999). Risk for Alzheimer's disease in older late-onset cases is associated with HLA-DRB1*03. Neurosci Lett, 275(2), 137-140. Abstract.  Author URL.
Ballard CG, Ayre G, O'Brien J, Sahgal A, McKeith IG, Ince PG, Perry RH (1999). Simple standardised neuropsychological assessments aid in the differential diagnosis of dementia with Lewy bodies from Alzheimer's disease and vascular dementia. Dementia and Geriatric Cognitive Disorders, 10(2), 104-108. Abstract.
Piggott MA, Marshall EF, Thomas N, Lloyd S, Court JA, Jaros E, Burn D, Johnson M, Perry RH, McKeith IG, et al (1999). Striatal dopaminergic markers in dementia with Lewy bodies, Alzheimer's and Parkinson's diseases: rostrocaudal distribution. BRAIN, 122, 1449-1468. Author URL.
Ballard CG, Shaw F, Lowery K, McKeith I, Kenny R (1999). The prevalence, assessment and associations of falls in dementia with Lewy bodies and Alzheimer's disease. Dementia and Geriatric Cognitive Disorders, 10(2), 97-103. Abstract.
Ballard C, O'Brien J (1999). Treating behavioural and psychological signs in Alzheimer's disease. British Medical Journal, 318(7203), 138-139.
Barber R, Scheltens P, Gholkar A, Ballard C, McKeith I, Ince P, Perry R, O'Brien J (1999). White matter lesions on magnetic resonance imaging in dementia with Lewy bodies, Alzheimer's disease, vascular dementia, and normal aging. J Neurol Neurosurg Psychiatry, 67(1), 66-72. Abstract.  Author URL.
Martin-Ruiz CM, Court JA, Molnar E, Lee M, Gotti C, Mamalaki A, Tsouloufis T, Tzartos S, Ballard C, Perry RH, et al (1999). α4 but not α3 and α7 nicotinic acetylcholine receptor subunits are lost from the temporal cortex in Alzheimer's disease. Journal of Neurochemistry, 73(4), 1635-1640. Abstract.
Singleton AB, Gibson AM, McKeith IG, Ballard CA, Perry RH, Ince PG, Edwardson JA, Morris CM (1999). α<inf>2</inf>-macroglobulin polymorphisms in Alzheimer's disease and dementia with Lewy bodies. NeuroReport, 10(7), 1507-1510. Abstract.
Ballard CG, O'Brien J, Lowery K, Ayre GA, Harrison R, Perry R, Ince P, Neill D, McKeith IG (1998). A prospective study of dementia with Lewy bodies. Age Ageing, 27(5), 631-636. Abstract.  Author URL.
Perry E, Court J, Goodchild R, Griffiths M, Jaros E, Johnson M, Lloyd S, Piggott M, Spurden D, Ballard C, et al (1998). Clinical neurochemistry: developments in dementia research based on brain bank material. J Neural Transm (Vienna), 105(8-9), 915-933. Abstract.  Author URL.
Ballard C, Shaw F, McKeith L, Kenny R (1998). High prevalence of neurovascular instability in neurodegenerative dementias. Neurology, 51(6), 1760-1762. Abstract.
Ballard C, Grace J, McKeith I, Holmes C (1998). Neuroleptic sensitivity in dementia with lewy bodies and Alzheimer's disease. Lancet, 351(9108), 1032-1033.
Bannister C, Ballard C, Lana M, Fairbairn A, Wilcock G (1998). Placement of dementia sufferers in residential and nursing home care. Age and Ageing, 27(2), 189-194. Abstract.
Ballard C, McKeith IG (1998). Psychiatric features in diffuse Lewy body disease. Neurology, 50(2).
McKeith' IG, Ince P, Jaros EB, Fairbairn A, Ballard C, Grace J, Morris CM, Perry RH (1998). What are the relations between Lewy body disease and AD?. Journal of Neural Transmission, Supplement(54), 107-116. Abstract.
Ballard C, McKeith I, Harrison R, O'Brien J, Thompson P, Lowery K, Perry R, Ince P (1997). A detailed phenomenological comparison of complex visual hallucinations in dementia with Lewy bodies and Alzheimer's disease. Int Psychogeriatr, 9(4), 381-388. Abstract.  Author URL.
Ballard C, O'Brien J, Coope B, Fairbairn A, Abid F, Wilcock G (1997). A prospective study of psychotic symptoms in dementia sufferers: Psychosis in dementia. International Psychogeriatrics, 9(1), 57-64. Abstract.
Ballard C, Massey H, Lamb H, Morris C (1997). Apolipoprotein E: non-cognitive symptoms and cognitive decline in late onset Alzheimer's disease. J Neurol Neurosurg Psychiatry, 63(2), 273-274. Author URL.
Graham C, Ballard C, Sham P (1997). Carers' knowledge of dementia and their expressed concerns. International Journal of Geriatric Psychiatry, 12(4), 470-473. Abstract.
Graham C, Ballard C, Sham P (1997). Carers' knowledge of dementia, their coping strategies and morbidity. International Journal of Geriatric Psychiatry, 12(9), 931-936. Abstract.
Graham C, Ballard C, Sham P (1997). Carers' knowledge of dementia, their coping strategies and morbidity. INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY, 12(9), 931-936. Author URL.
Ballard C, Coope B, Oyebode F, Wilcock G (1997). Depression in dementia sufferers - Comparison of diagnostic criteria. Journal of the American Geriatrics Society, 45(1), 123-124.
Cullen P, Abid F, Patel A, Coope B, Ballard CG (1997). Eating disorders in dementia. International Journal of Geriatric Psychiatry, 12(5), 559-562. Abstract.
Cullen P, Abid F, Patel A, Coope B, Ballard CG (1997). Eating disorders in dementia. INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY, 12(5), 559-562. Author URL.
Ballard CG, O'Brien JT, Coope B, Wilcock G (1997). Psychotic symptoms in dementia and the rate of cognitive decline. Journal of the American Geriatrics Society, 45(8), 1031-1032.
Ballard CG, Solis M, Gahir M, Cullen P, George S, Oyebode F, Wilcock G (1997). Sexual relationships in married dementia sufferers. International Journal of Geriatric Psychiatry, 12(4), 447-451. Abstract.
Ballard C, McKeith I, Burn D, Harrison R, O'Brien J, Lowery K, Campbell M, Perry R, Ince P (1997). The UPDRS scale as a means of identifying extrapyramidal signs in patients suffering from dementia with Lewy bodies. Acta Neurol Scand, 96(6), 366-371. Abstract.  Author URL.
Graham C, Ballard C, Saad K (1997). Variables which distinguish patients fulfilling clinical criteria for dementia with Lewy bodies from those with Alzheimer's disease. International Journal of Geriatric Psychiatry, 12(3), 314-318. Abstract.
Graham C, Ballard C, Saad K (1997). Variables which distinguish patients fulfilling clinical criteria for dementia with Lewy bodies from those with Alzheimer's disease. INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY, 12(3), 314-318. Author URL.
Ballard CG, Eastwood C, Gahir M, Wilcock G (1996). A follow up study of depression in the carers of dementia sufferers. British Medical Journal, 312(7036).
Ballard CG, Patel A, Solis M, Lowe K, Wilcock G (1996). A one-year follow-up study of depression in dementia sufferers. British Journal of Psychiatry, 168(MAR.), 287-291. Abstract.
Ballard C, Boyle A, Bowler C, Lindesay J (1996). Anxiety disorders in dementia sufferers. International Journal of Geriatric Psychiatry, 11(11), 987-990. Abstract.
Ballard C, Patel A, Oyebode F, Wilcock G (1996). Cognitive decline in patients with Alzheimer's disease, vascular dementia and senile dementia of Lewy body type. Age and Ageing, 25(3), 209-213. Abstract.
McKeith IG, Galasko D, Kosaka K, Perry EK, Dickson DW, Hansen LA, Salmon DP, Lowe J, Mirra SS, Byrne EJ, et al (1996). Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): Report of the consortium on DLB international workshop. Neurology, 47(5), 1113-1124. Abstract.
Ballard CG, Bannister C, Oyebode F (1996). Depression in dementia sufferers. International Journal of Geriatric Psychiatry, 11(6), 507-515. Abstract.
Ballard CG, Bannister C, Oyebode F (1996). Depression in dementia sufferers. INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY, 11(6), 507-515. Author URL.
Ballard C, Davies R (1996). Postnatal depression in fathers. International Review of Psychiatry, 8(1), 65-71. Abstract.
Ballard C, Bannister C, Solis M, Oyebode F, Wilcock G (1996). The prevalence, associations and symptoms of depression amongst dementia sufferers. Journal of Affective Disorders, 36(3), 135-144. Abstract.
Ballard C, Bannister C, Graham C, Oyebode F, Wilcock G (1995). Associations of psychotic symptoms in dementia sufferers. British Journal of Psychiatry, 167(OCT.), 537-540. Abstract.
Ballard CG, Bannister CL, Patel A, Graham C, Oyebode F, Wilcock G, Chung MC (1995). Classification of psychotic symptoms in dementia sufferers. Acta Psychiatrica Scandinavica, 92(1), 63-68. Abstract.
Saad K, Hartman J, Ballard C, Kurian M, Graham C, Wilcock G (1995). Coping by the carers of dementia sufferers. Age and Ageing, 24(6), 495-498. Abstract.
McKeith IG, Ballard CG, Harrison RWS (1995). Neuroleptic sensitivity to risperidone in Lewy body dementia. The Lancet, 346(8976).
Ballard CG, Stanley AK, Brockington IF (1995). Post-traumatic stress disorder (PTSD) after childbirth. British Journal of Psychiatry, 166(APR.), 525-528. Abstract.
Ballard C, Oyebode F (1995). Psychotic symptoms in patients with dementia. International Journal of Geriatric Psychiatry, 10(9), 743-752. Abstract.
Ballard CG, Saad K, Coope B, Graham C, Gahir M, Wilcock GK, Oyebode F (1995). The aetiology of depression in the carers of dementia sufferers. Journal of Affective Disorders, 35(1-2), 59-63. Abstract.
Ballard CG, Saad K, Patel A, Gahir M, Solis M, Coope B, Wilcock G (1995). The prevalence and phenomenology of psychotic symptoms in dementia sufferers. International Journal of Geriatric Psychiatry, 10(6), 477-485. Abstract.
Coope B, Ballard C, Saad K, Patel A, Bentham P, Bannister C, Graham C, Wilcock G (1995). The prevalence of depression in the carers of dementia sufferers. International Journal of Geriatric Psychiatry, 10(3), 237-242. Abstract.
Cassidy G, Ballard CG (1994). Brief reports: Psychiatric sequelae of mdma (ecstasy) and related drugs. Irish Journal of Psychological Medicine, 11(3), 132-133. Abstract.
England SJ, Ballard C, George S (1994). Chronicity in postnatal depression. European Journal of Psychiatry, 8(2), 93-96. Abstract.
Ballard CG, Mohan RN, Patel A, Graham C (1994). Original Papers: Anxiety disorder in dementia. Irish Journal of Psychological Medicine, 11(3), 108-109. Abstract.
Ballard CG, Davis R, Cullen PC, Mohan RN, Dean C (1994). Prevalence of postnatal psychiatric morbidity in mothers and fathers. British Journal of Psychiatry, 164(JUNE), 782-788. Abstract.
Ballard CG, Handy S, McGibben L, Mohan RNC, Silveira WR (1993). Eating disorder in a 6‐year‐old Asian girl with ethyl malonic adipic aciduria. International Journal of Eating Disorders, 13(2), 245-248. Abstract.
Chithiramohan RN, Ballard CG, Baxter MA, Jones L, Handy S, Sheikh A, McGibben L, Silveira R (1993). Factors influencing general practitioner referral to a child psychiatric service. Irish Journal of Psychological Medicine, 10(3), 144-147. Abstract.
Ballard CG, Mohan RNC, Patel A, Bannister C (1993). Idiopathic clouding of consciousness—do the patients have cortical lewy body disease?. International Journal of Geriatric Psychiatry, 8(7), 571-576. Abstract.
Ballard CG, Davis R, Handy S, Mohan RNC (1993). Postpartum anxiety in mothers and fathers. European Journal of Psychiatry, 7(2), 117-121. Abstract.
Ballard CG, Cassidy G, Bannister C, Mohan RNC (1993). Prevalence, symptom profile, and aetiology of depression in dementia sufferers. Journal of Affective Disorders, 29(1), 1-6. Abstract.
Ballard CG, Mohan RNC, Davis R (1993). Seasonal variation in the prevalence of postnatal depression. European Journal of Psychiatry, 7(2), 73-76. Abstract.
Ballard CG, Mohan RNC, Handy S (1992). Chronic depersonalisation neurosis au Shorvon - a successful intervention. British Journal of Psychiatry, 160(JAN.), 123-125. Abstract.
McGibben L, Ballard CG, Handy S, Mohan RNC, Silveira WR (1992). Deliberate self-poisoning in Asian and Caucasian 12-15-year-olds. British Journal of Psychiatry, 161(JULY), 110-112. Abstract.
McGibben L, Ballard CG, Handy S, Silveira WR (1992). School attendance as a factor in deliberate self poisoning by 12-15 year old adolescents. British Medical Journal, 304(6818).
Ballard CG, Kurian M, Silveira WR (1992). The phenomena of “bingeing”. Irish Journal of Psychological Medicine, 9(1), 61-62. Abstract.
MCGIBBON L, HANDY S, BALLARD CG, SILVEIRA WR (1991). ANOREXIA-NERVOSA ACROSS CULTURES. BRITISH JOURNAL OF PSYCHIATRY, 158, 284-285. Author URL.
McGibbon L, Handy S, Ballard CG, Silveira WR (1991). Anorexia nervosa across cultures (II). British Journal of Psychiatry, 158(FEB.).
Ballard CG, Mohan RNC, Handy S (1991). Carbamazepine in alcohol withdrawal. British Journal of Psychiatry, 158(JAN.).
McGibben L, Ballard C (1991). Child psychiatry liaison services [7]. British Journal of Psychiatry, 158(APR.).
Ballard C, Bannister C, Davis R, Handy S, Cullen P (1991). Christmas census at a district general hospital psychiatric unit. Irish Journal of Psychological Medicine, 8(1), 46-47. Abstract.
Handy S, Chithiramohan RN, Ballard CG, Silveira WR (1991). Ethnic differences in adolescent self-poisoning: a comparison of Asian and Caucasian groups. Journal of Adolescence, 14(2), 157-162. Abstract.
Ballard CG, Chithiramohan RN, Handy S, Bannister C, Davis R, Todd NB (1991). Information reliability in dementia sufferers. International Journal of Geriatric Psychiatry, 6(5), 313-316. Abstract.
Ballard CG, Chithiramohan RN, Bannister C, Handy S, Todd N (1991). Paranoid features in the elderly with dementia. International Journal of Geriatric Psychiatry, 6(3), 155-157. Abstract.
Ballard C, Ing R, Cullen P, Chithiramohan R (1991). Sexual abuse: Crisis and response to counseling. Journal of Forensic Psychiatry, 2(2), 211-216. Abstract.
Ballard CG, Chithiramohan RN, Handy S (1991). The charles bonnet syndrome associated with vascular pathology — a classical presentation with a very atypical course. Irish Journal of Psychological Medicine, 8(1), 44-45. Abstract.
Handy S, Chithiramohan RN, Ballard CG, Bannister C, Rusca R (1991). The rationale of patient allocation for psychogeriatric assessment. International Journal of Geriatric Psychiatry, 6(4), 249-252. Abstract.
Cullen P, Ballard CG, Ing RP, Mohan RNC (1991). Vulnerability, coping and crisis. European Journal of Psychiatry, 5(4), 210-215. Abstract.
Ballard CG, Mohan RNC, Bannister C, Handy S, Patel A (1991). Wandering in dementia sufferers. International Journal of Geriatric Psychiatry, 6(8), 611-614. Abstract.
Chithiramohan RN, Ballard CG, Measey LG (1990). Acute dystonia induced by clomipramine therapy. Irish Journal of Psychological Medicine, 7(2), 141-142. Abstract.
Ballard C (1990). Cognitive and emotional improvement in a group of dementia patients. Acta psychiatrica Scandinavica, 81(1).
Ballard C (1990). Letter to the editor. Acta Psychiatrica Scandinavica, 81(1), 96-96.
Ballard CG, Chithiramohan RN, Handy S (1990). Skeleton services. British Journal of Psychiatry, 157(SEPT.), 455-456.
Ballard CG (1989). Benign intracranial hypertension and repeated self-mutilation. The British journal of psychiatry : the journal of mental science, 155, 570-571.
Ballard C (1989). NMS and thioxanthenes. The British journal of psychiatry : the journal of mental science, 155, 127-128.
Ballard CG (1989). Nosological problems. The British journal of psychiatry : the journal of mental science, 154
Ballard CG (1989). Physical morbidity of psychiatric patients. British Journal of Psychiatry, 155
Ballard CG (1989). Successful therapeutic intervention in a schizophrenic patient with blepharospasm. Journal of Neurology Neurosurgery and Psychiatry, 52(11).

Chapters

Corbett A, Ballard C, Creese BA (2018). Evidence-based management of behavioural and psychological symptoms of dementia. In Michel J-P, Beattie BL, Martin FC, Walston JD (Eds.) Oxford Textbook of Geriatric Medicine, Oxford University Press, 1015-1020.  Abstract.
Duara R, Rodriguez MJ, Loewenstein DA, Farlow MR, Ballard C, Chui HC, Segal-Gidan F, Perry D, Rosen H, Henry ML, et al (2014). Cognitive Impairment and the Dementias. In  (Ed) Geriatric Neurology, 181-286.  Abstract.
Ballard C, Corbett A (2012). Management of agitation and aggression: Controversies and possible solutions. In  (Ed) Advances in Alzheimer's Disease Management, 69-79.
Wheater HS, Ballard C, Bulygina N, McIntyre N, Jackson BM (2012). Modelling environmental change: Quantification of impacts of land use and land management change on UK flood risk. In  (Ed) System Identification, Environmental Modelling, and Control System Design, 449-481.  Abstract.
Ballard C, Aarsland D (2011). Pharmacological management of neuropsychiatric symptoms in people with dementia. In  (Ed) Supportive Care for the Person with Dementia.  Abstract.
Wheater HS, McIntyre N, Jackson BM, Marshall MR, Ballard C, Bulygina NS, Reynolds B, Frogbrook Z (2010). Multiscale Impacts of Land Management on Flooding. In  (Ed) Flood Risk Science and Management, 39-59.
Ballard C, Chitramohan R, Khan Z, Beh J (2010). NHS Continuing Care. In  (Ed) Principles and Practice of Geriatric Psychiatry: Third Edition, 759-765.  Abstract.
Sharp SI, Francis PT, Ballard CG (2006). Cholinergic and Serotonergic Systems in Severe Dementia. In  (Ed) Severe Dementia, 21-31.

Conferences

Atri A, Frölich L, Ballard C, Tariot PN, Molinuevo JL, Boneva N, Windfeld K, Raket LL, Cummings JL (2018). Effect of idalopirdine as adjunct to cholinesterase inhibitors on change in cognition in patients with Alzheimer disease three randomized clinical trials.  Abstract.
Blesa R, Ballard C, Orgogozo JM, Lane R, Thomas SK (2007). Caregiver preference for rivastigmine patches versus capsules for the treatment of Alzheimer disease.  Abstract.
Ballard C, Sorensen S, Sharp S (2007). Pharmacological therapy for people with Alzheimer's disease: the balance of clinical effectiveness, ethical issues and social and healthcare costs.  Abstract.
Ballard CG, Greig NH, Guillozet-Bongaarts AL, Enz A, Darvesh S (2005). Cholinesterases: Roles in the brain during health and disease.  Abstract.
Ballard CG, Margallo-Lana ML (2004). The relationship between antipsychotic treatment and quality of life for patients with dementia living in residential and nursing home care facilities.  Abstract.
Kalaria RN, Kenny RA, Ballard CG, Perry R, Ince P, Polvikoski T (2004). Towards defining the neuropathological substrates of vascular dementia.  Abstract.  Author URL.
Ballard C, Stephens S, McLaren A, Wesnes K, Kenny R (2003). Mild cognitive impairment and vascular cognitive impairment in stroke patients.  Abstract.
Kenny RAM, Kalaria R, Ballard C (2002). Neurocardiovascular instability in cognitive impairment and dementia.  Abstract.
Ballard C, Stephens S, McLaren A, Wesnes K, Kenny RA, Burton E, O'Brien J, Kalaria R (2002). Neuropsychological deficits in older stroke patients.  Abstract.
Ballard C, Lowery K, Powell I, O'Brien J, James I (2000). Impact of behavioral and psychological symptoms of dementia on caregivers.
Ballard C, O'Brien J, Barber B, Scheltens P, Shaw F, Mckeith I, Kenny RA (2000). Neurocardiovascular instability, hypotensive episodes, and MRI lesions in neurodegenerative dementia.  Abstract.
Perry E, Martin-Ruiz C, Lee M, Griffiths M, Johnson M, Piggott M, Haroutunian V, Buxbaum JD, Nãsland J, Davis K, et al (2000). Nicotinic receptor subtypes in human brain ageing, Alzheimer and Lewy body diseases.  Abstract.  Author URL.
Martin-Ruiz C, Court J, Lee M, Piggott M, Johnson M, Ballard C, Kalaria R, Perry R, Perry E (2000). Nicotinic receptors in dementia of Alzheimer, Lewy body and vascular types.  Abstract.  Author URL.

Publications by year


In Press

Ballard C, Mobley W, Hardy J, Williams G, Corbett A (In Press). Dementia in Down's syndrome. Lancet Neurol, 15(6), 622-636. Abstract.  Author URL.
Surr CA, Walwyn REA, Lilley-Kelly A, Cicero R, Meads D, Ballard C, Burton K, Chenoweth L, Corbett A, Creese B, et al (In Press). Evaluating the effectiveness and cost-effectiveness of Dementia Care Mapping™ to enable person-centred care for people with dementia and their carers (DCM-EPIC) in care homes: study protocol for a randomised controlled trial. Trials, 17(1). Abstract.  Author URL.  Full text.
Wesnes KA, Brooker H, Ballard C, McCambridge L, Stenton R, Corbett A (In Press). Utility, reliability, sensitivity and validity of an online test system designed to monitor changes in cognitive function in clinical trials. Int J Geriatr Psychiatry, 32(12), e83-e92. Abstract.  Author URL.  Full text.

2018

Pickett J, Bird C, Ballard C, Banerjee S, Brayne C, Cowan K, Clare L, Comas-Herrera A, Corner L, Daley S, et al (2018). A roadmap to advance dementia research in prevention, diagnosis, intervention, and care by 2025. Int J Geriatr Psychiatry, 33(7), 900-906. Abstract.  Author URL.  Full text.
Ballard C, Lang I (2018). Alcohol and dementia: a complex relationship with potential for dementia prevention. The Lancet Public Health, 3(3), e103-e104.
Atri A, Frölich L, Ballard C, Tariot PN, Molinuevo JL, Boneva N, Windfeld K, Raket LL, Cummings JL (2018). Effect of idalopirdine as adjunct to cholinesterase inhibitors on change in cognition in patients with Alzheimer disease three randomized clinical trials.  Abstract.
Erdal A, Flo E, Aarsland D, Ballard C, Slettebo DD, Husebo BS (2018). Efficacy and Safety of Analgesic Treatment for Depression in People with Advanced Dementia: Randomised, Multicentre, Double-Blind, Placebo-Controlled Trial (DEP.PAIN.DEM). Drugs and Aging, 35(6), 545-558. Abstract.
Ballard C, Banister C, Khan Z, Cummings J, Demos G, Coate B, Youakim JM, Owen R, Stankovic S, Tomkinson EB, et al (2018). Evaluation of the safety, tolerability, and efficacy of pimavanserin versus placebo in patients with Alzheimer's disease psychosis: a phase 2, randomised, placebo-controlled, double-blind study. The Lancet Neurology, 17(3), 211-212. Abstract.
Corbett A, Ballard C, Creese BA (2018). Evidence-based management of behavioural and psychological symptoms of dementia. In Michel J-P, Beattie BL, Martin FC, Walston JD (Eds.) Oxford Textbook of Geriatric Medicine, Oxford University Press, 1015-1020.  Abstract.
Petyaeva A, Kajander M, Lawrence V, Clifton L, Thomas AJ, Ballard C, Leroi I, Briggs M, Closs J, Dening T, et al (2018). Feasibility of a staff training and support programme to improve pain assessment and management in people with dementia living in care homes. Int J Geriatr Psychiatry, 33(1), 221-231. Abstract.  Author URL.
Creese B, Bell E, Johar I, Francis P, Ballard C, Aarsland D (2018). Glucocerebrosidase mutations and neuropsychiatric phenotypes in Parkinson's disease and Lewy body dementias: Review and meta-analyses. Am J Med Genet B Neuropsychiatr Genet, 177(2), 232-241. Abstract.  Author URL.
Mueller C, Perera G, Rajkumar AP, Bhattarai M, Price A, O'Brien JT, Ballard C, Stewart R, Aarsland D (2018). Hospitalization in people with dementia with Lewy bodies: Frequency, duration, and cost implications. Alzheimer's and Dementia: Diagnosis, Assessment and Disease Monitoring, 10, 143-152. Abstract.
Ballard C, Corbett A, Orrell M, Williams G, Moniz-Cook E, Romeo R, Woods B, Garrod L, Testad I, Woodward-Carlton B, et al (2018). Impact of person-centred care training and person-centred activities on quality of life, agitation, and antipsychotic use in people with dementia living in nursing homes: a cluster-randomised controlled trial. PLoS Med, 15(2). Abstract.  Author URL.
Huntley J, Corbett A, Wesnes K, Brooker H, Stenton R, Hampshire A, Ballard C (2018). Online assessment of risk factors for dementia and cognitive function in healthy adults. Int J Geriatr Psychiatry, 33(2), e286-e293. Abstract.  Author URL.
Bereczki E, Branca RM, Francis PT, Pereira JB, Baek JH, Hortobágyi T, Winblad B, Ballard C, Lehtiö J, Aarsland D, et al (2018). Synaptic markers of cognitive decline in neurodegenerative diseases: a proteomic approach. Brain, 141(2), 582-595. Abstract.
Ballard C, Testad I (2018). TIME in the Context of Emerging Evidence Regarding Training Interventions for Dementia in Nursing Homes. Am J Geriatr Psychiatry, 26(1), 39-41. Author URL.
Creese B, Da Silva MV, Johar I, Ballard C (2018). The modern role of antipsychotics for the treatment of agitation and psychosis in Alzheimer's disease. Expert Rev Neurother, 18(6), 461-467. Abstract.  Author URL.  Full text.
Erdal A, Flo E, Aarsland D, Selbaek G, Ballard C, Slettebo DD, Husebo BS (2018). Tolerability of buprenorphine transdermal system in nursing home patients with advanced dementia: a randomized, placebo-controlled trial (DEP.PAIN.DEM). Clinical Interventions in Aging, 13, 935-946. Abstract.

2017

Skogseth R, Hortobágyi T, Soennesyn H, Chwiszczuk L, Ffytche D, Rongve A, Ballard C, Aarsland D (2017). Accuracy of clinical diagnosis of dementia with lewy bodies versus neuropathology. Journal of Alzheimer's Disease, 59(4), 1139-1152. Abstract.
Aarsland D, Creese B, Politis M, Chaudhuri KR, Ffytche DH, Weintraub D, Ballard C (2017). Cognitive decline in Parkinson disease. Nat Rev Neurol, 13(4), 217-231. Abstract.  Author URL.
Webster L, Groskreutz D, Grinbergs-Saull A, Howard R, O'Brien JT, Mountain G, Banerjee S, Woods B, Perneczky R, Lafortune L, et al (2017). Core outcome measures for interventions to prevent or slow the progress of dementia for people living with mild to moderate dementia: Systematic review and consensus recommendations. PLoS One, 12(6). Abstract.  Author URL.  Full text.
Knapp M, King D, Romeo R, Adams J, Baldwin A, Ballard C, Banerjee S, Barber R, Bentham P, Brown RG, et al (2017). Cost-effectiveness of donepezil and memantine in moderate to severe Alzheimer's disease (the DOMINO-AD trial). International Journal of Geriatric Psychiatry, 32(12), 1205-1216. Abstract.
Livingston G, Sommerlad A, Orgeta V, Costafreda SG, Huntley J, Ames D, Ballard C, Banerjee S, Burns A, Cohen-Mansfield J, et al (2017). Dementia prevention, intervention, and care. The Lancet, 390(10113), 2673-2734.
Webster L, Groskreutz D, Grinbergs-Saull A, Howard R, O'Brien JT, Mountain G, Banerjee S, Woods B, Perneczky R, Lafortune L, et al (2017). Development of a core outcome set for disease modification trials in mild to moderate dementia: a systematic review, patient and public consultation and consensus recommendations. Health Technol Assess, 21(26), 1-192. Abstract.  Author URL.  Full text.
McKeith IG, Boeve BF, Dickson DW, Halliday G, Taylor J-P, Weintraub D, Aarsland D, Galvin J, Attems J, Ballard CG, et al (2017). Diagnosis and management of dementia with Lewy bodies Fourth consensus report of the DLB Consortium. NEUROLOGY, 89(1), 88-100. Author URL.
Khan A, Corbett A, Ballard C (2017). Emerging amyloid and tau targeting treatments for Alzheimer's disease. Expert Rev Neurother, 17(7), 697-711. Abstract.  Author URL.
Khan A, Corbett A, Ballard C (2017). Emerging treatments for Alzheimer's disease for non-amyloid and non-tau targets. Expert Rev Neurother, 17(7), 683-695. Abstract.  Author URL.
Rajkumar AP, Ballard C, Fossey J, Orrell M, Moniz-Cook E, Woods RT, Murray J, Whitaker R, Stafford J, Knapp M, et al (2017). Epidemiology of Pain in People with Dementia Living in Care Homes: Longitudinal Course, Prevalence, and Treatment Implications. J Am Med Dir Assoc, 18(5), 453.e1-453.e6. Abstract.  Author URL.
Mueller C, Ballard C, Corbett A, Aarsland D (2017). Historical landmarks in dementia with Lewy bodies. Lancet Neurol, 16(5). Author URL.
Ballard C, Orrell M, Sun Y, Moniz-Cook E, Stafford J, Whitaker R, Woods B, Corbett A, Banerjee S, Testad I, et al (2017). Impact of antipsychotic review and non-pharmacological intervention on health-related quality of life in people with dementia living in care homes: WHELD-a factorial cluster randomised controlled trial. Int J Geriatr Psychiatry, 32(10), 1094-1103. Abstract.  Author URL.
Gatt A, Ekonomou A, Somani A, Thuret S, Howlett D, Corbett A, Johnson M, Perry E, Attems J, Francis P, et al (2017). Importance of Proactive Treatment of Depression in Lewy Body Dementias: the Impact on Hippocampal Neurogenesis and Cognition in a Post-Mortem Study. Dement Geriatr Cogn Disord, 44(5-6), 283-293. Abstract.  Author URL.
Chong JR, Chai YL, Lee JH, Howlett D, Attems J, Ballard CG, Aarsland D, Francis PT, Chen CP, Lai MKP, et al (2017). Increased transforming growth factor β2 in the neocortex of Alzheimer's disease and dementia with lewy bodies is correlated with disease severity and soluble Aβ<inf>42</inf>load. Journal of Alzheimer's Disease, 56(1), 157-166. Abstract.
Bath PM, Scutt P, Blackburn DJ, Ankolekar S, Krishnan K, Ballard C, Burns A, Mant J, Passmore P, Pocock S, et al (2017). Intensive versus Guideline Blood Pressure and Lipid Lowering in Patients with Previous Stroke: Main results from the pilot prevention of Decline in Cognition after Stroke trial' (PODCAST) randomised controlled trial. PLoS ONE, 12(1). Abstract.
Chai YL, Xing H, Chong JR, Francis PT, Ballard CG, Chen CP, Lai MKP (2017). Mitochondrial Translocase of the Outer Membrane Alterations May Underlie Dysfunctional Oxidative Phosphorylation in Alzheimer's Disease. Journal of Alzheimer's Disease, 61(2), 793-801. Abstract.
Lanctôt KL, Amatniek J, Ancoli-Israel S, Arnold SE, Ballard C, Cohen-Mansfield J, Ismail Z, Lyketsos C, Miller DS, Musiek E, et al (2017). Neuropsychiatric signs and symptoms of Alzheimer's disease: New treatment paradigms. Alzheimer's and Dementia: Translational Research and Clinical Interventions, 3(3), 440-449. Abstract.
Velayudhan L, Ffytche D, Ballard C, Aarsland D (2017). New Therapeutic Strategies for Lewy Body Dementias. Current Neurology and Neuroscience Reports, 17(9). Abstract.
Hammond SP, Cross JL, Shepstone L, Backhouse T, Henderson C, Poland F, Sims E, MacLullich A, Penhale B, Howard R, et al (2017). PERFECTED enhanced recovery (PERFECT-ER) care versus standard acute care for patients admitted to acute settings with hip fracture identified as experiencing confusion: study protocol for a feasibility cluster randomized controlled trial. Trials, 18(1). Abstract.  Author URL.
Alghamdi A, Vallortigara J, Howlett DR, Broadstock M, Hortobágyi T, Ballard C, Thomas AJ, O'Brien JT, Aarsland D, Attems J, et al (2017). Reduction of RPT6/S8 (a Proteasome Component) and Proteasome Activity in the Cortex is Associated with Cognitive Impairment in Lewy Body Dementia. J Alzheimers Dis, 57(2), 373-386. Abstract.  Author URL.
Ffytche DH, Pereira JB, Ballard C, Chaudhuri KR, Weintraub D, Aarsland D (2017). Risk factors for early psychosis in PD: Insights from the Parkinson's Progression markers initiative. Journal of Neurology, Neurosurgery and Psychiatry, 88(4), 325-331. Abstract.
Romeo R, Knapp M, Salverda S, Orrell M, Fossey J, Ballard C (2017). The cost of care homes for people with dementia in England: a modelling approach. International Journal of Geriatric Psychiatry, 32(12), 1466-1475. Abstract.
Mueller C, Ballard C, Corbett A, Aarsland D (2017). The prognosis of dementia with Lewy bodies. Lancet Neurol, 16(5), 390-398. Abstract.  Author URL.
Ffytche DH, Creese B, Politis M, Chaudhuri KR, Weintraub D, Ballard C, Aarsland D (2017). The psychosis spectrum in Parkinson disease. Nat Rev Neurol, 13(2), 81-95. Abstract.  Author URL.

2016

Greenan C, Murphy L, Yu LM, Kehoe PG, Coulthard E, Bath P, Stewart R, Jones R, Corbett A, Thomas A, et al (2016). A randomised controlled trial of calcium channel blockade (CCB) with Amlodipine for the treatment oF subcortical ischaEmic vasCular demenTia (AFFECT): Study protocol. Trials, 17(1). Abstract.  Full text.
Enache D, Fereshtehnejad SM, Kï reholt I, Cermakova P, Garcia-Ptacek S, Johnell K, Religa D, Jelic V, Winblad B, Ballard C, et al (2016). Antidepressants and mortality risk in a dementia cohort: data from SveDem, the Swedish Dementia Registry. Acta Psychiatrica Scandinavica, 134(5), 430-440. Abstract.
Selbæk G, Aarsland D, Ballard C, Engedal K, Langballe EM, Benth JŠ, Bergh S (2016). Antipsychotic Drug Use is Not Associated with Long-Term Mortality Risk in Norwegian Nursing Home Patients. Journal of the American Medical Directors Association, 17(5), 464.e1-464.e7. Abstract.
Rajkumar AP, Ballard C, Fossey J, Corbett A, Woods B, Orrell M, Prakash R, Moniz-Cook E, Testad I (2016). Apathy and its Response to Antipsychotic Review and Nonpharmacological Interventions in People with Dementia Living in Nursing Homes: WHELD, a Factorial Cluster Randomized Controlled Trial. Journal of the American Medical Directors Association, 17(8), 741-747. Abstract.
Lovestone S, Rossor M, Gallacher J, Ritchie C, Burn D, Hyslop PSG, Mackay C, Matthews PM, Ballard C, Georges J, et al (2016). Better together for better dementia research and care. The Lancet Psychiatry, 3(6), 503-504.
Rongve A, Soennesyn H, Skogseth R, Oesterhus R, Hortobágyi T, Ballard C, Auestad BH, Aarsland D (2016). Cognitive decline in dementia with Lewy bodies: a 5-year prospective cohort study. BMJ Open, 6(2). Abstract.
Winblad B, Amouyel P, Andrieu S, Ballard C, Brayne C, Brodaty H, Cedazo-Minguez A, Dubois B, Edvardsson D, Feldman H, et al (2016). Defeating Alzheimer's disease and other dementias: a priority for European science and society. The Lancet Neurology, 15(5), 455-532.